Home
  >  
Section 43

EurekaMag Full Text Articles Chapter 42,023



References:

De Almeida, J.C.; Barcinski, M.A.; do Céu Abreu, M.; Naya, J.; Kayath, H.C.; Cunha, A.G.; Schulz, I.; Mello, R.S.; Rita Santos, R. 1974: 45,X-46,Xr(Y) in a case of asymmetrical testicular differentiation. Annales de Genetique 17(1): 37-40
Uchida, I.A.; deSa, D.J.; Whelan, D.T. 1983: 45,X/46,XX mosaicism in discordant monozygotic twins. Pediatrics 71(3): 413-417
Hecht, F.; Hecht, B.K. 1982: 45,X/46,XY chromosome mosaicism detected by midtrimester amniocentesis in amniocyte clones. Prenatal Diagnosis 2(3): 233-235
Sparagana, M.; Wong, P.W.; Dorsch, T.R.; Casten, C.; Rauer, M.; Szego, K. 1980: 45,X/46,XY/47,XY, +21 mosaicism in a hypogonadal phenotypic male. Journal of Medical Genetics 17(4): 319-321
Osztovics, M.; Ivády, G.; Ruzicska, P.; Bühler, E.M.; Király, L. 1974: 45,X/46,XY/47,XYY mosaicism in a phenotypic female with gonadoblastoma. Acta Paediatrica Academiae Scientiarum Hungaricae 15(3-4): 295-299
Wertelecki, W.; Shapiro, J.R. 1970: 45,XO Turner's syndrome and leukaemia. Lancet 1(7650): 789-790
Say, B.; Balci, S.; Tunçbilek, E. 1971: 45,XO Turner's syndrome, Wilm's tumor and imprforate anus. Humangenetik 12(4): 348-350
Soll, D.B. 1983: 45-Degree angled aspiration tip with sandblasted, roughened edge for posterior capsule polishing. Ophthalmic Surgery 14(8): 689
Lenzi, G. 1967: 45-XO gonadal dysgenesis with predominantly monolateral manifestation. Archivio "de Vecchi" Per l'Anatomia Patologica E la Medicina Clinica 50(1): 311-323
Mundinger, A.; Munderloh, K.H.; Schröder, F. 1984: 45-year-old patient with fever, changing organ symptoms, hypertension. Der Internist 25(6): 387-388
Vogelmeier, C.; Biedermann, T.; Gerth, A.; Witthaut, R.; Samtleben, W.; Heuck, A.; Steinbeck, G. 1994: 45-year-old patient with hepatosplenomegaly, polyneuropathy and M-gradient. Der Internist 35(12): 1156-1159
Kishimoto, U.; Okawa, K. 1973: 45. I-V curves and electromotive force of the Chara membrane. Nihon Seirigaku Zasshi. Journal of the Physiological Society of Japan 35(8): 400
Kourias, B. 1967: 45. Views on recurrent ulcer following gastric resection. Langenbecks Archiv für Chirurgie 319: 283-289
Haschek, H.; Schimatzek, A.; Vedrilla, D. 1974: 450 bladder carcinomas--5 years later. Münchener Medizinische Wochenschrift 116(32-33): 1452-1453
Lotto, A.; Lomanto, B.; Bossi, M.; Cantono, G.M.; Palminiello, L.; Palleni, R. 1970: 450 cases of acute myocardial infarct in a coronary care unit. Cardiologia Pratica 21(3): 165-176
Rosenheim, M. 1968: 450 years old--what of the future?. Annals of Internal Medicine 68(5): 1115-1120
Stout, M.A.; Diecke, F.P. 1983: 45Ca distribution and transport in saponin skinned vascular smooth muscle. Journal of Pharmacology and Experimental Therapeutics 225(1): 102-111
Zyzek, E.; Dufy, B.; Fleury, H.; Vincent, J.D. 1982: 45Ca flow from cultured pituitary cells: effect of TRH and potassium. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 176(3): 259-265
Burch, R.M.; Halushka, P.V. 1983: 45Ca fluxes in isolated toad bladder epithelial cells: effects of agents which alter water or sodium transport. Journal of Pharmacology and Experimental Therapeutics 224(1): 108-117
Hagiwara, E.; Nagai, T. 1970: 45Ca movements at rest and during potassium contracture in Mytilus ABRM. Japanese Journal of Physiology 20(1): 72-83
Yu, J.H.; Jirakulsomchok, D.; Schneyer, C.A. 1982: 45Ca uptake and secretion by nerve-stimulated parotid glands of rats. Alabama Journal of Medical Sciences 19(2): 139-141
Urakawa, N.; Karaki, H.; Ikeda, M. 1968: 45Ca uptake and tissue Ca of guinea pig taenia coli in isotonic high-K-Na-deficient medium. Japanese Journal of Pharmacology 18(3): 294-298
Milligan, J.V.; Kraicer, J. 1971: 45Ca uptake during the in vitro release of hormones from the rat adenohypophysis. Endocrinology 89(3): 766-773
Misra, V.; Lal, H.; Viswanathan, P.N.; Murti, C.R. 1984: 45Ca uptake from water by snails (Lymnaea vulgaris) in control and detergent-polluted samples. Ecotoxicology and Environmental Safety 8(1): 97-99
Molnar, S. 1970: 45Ca-activity in the body of living pigs. Zeitschrift für Tierphysiologie Tierernahrung und Futtermittelkunde 26(1): 59-61
Kim, N.D.; Harrison, C.E. 1974: 45Ca2+ accumulation by mitochondria and sarcoplasmic reticulum in chronic potassium depletion cardiomyopathy. Recent Advances in Studies on Cardiac Structure and Metabolism 4: 551-562
Kraus-Friedmann, N.; Zimniak, P. 1983: 45Ca2+ uptake and phospholipid methylation in isolated rat liver microsomes. Cell Calcium 4(3): 139-150
Mańkowski, T.; Helwich, E.; Piekarczyk, A.; Swirska, A.; Wierzba, K. 1984: 45Ca2+ uptake by rat thymocytes in the presence of blood serum of patients with cystic fibrosis. Problemy Medycyny Wieku Rozwojowego 13: 213-218
Daniell, L.C.; Barr, E.M.; Leslie, S.W. 1983: 45Ca2+ uptake into rat whole brain synaptosomes unaltered by dihydropyridine calcium antagonists. Journal of Neurochemistry 41(5): 1455-1459
Schiessel, C.; Forsthove, C.; Keppler, D. 1984: 45Calcium uptake during the transition from reversible to irreversible liver injury induced by D-galactosamine in vivo. Hepatology 4(5): 855-861
Bayard, F.; Louvet, J.P.; Salanova, J.; Boulard, C. 1972: 45X-46XY mosaicism with normal male phenotype and delayed puberty. Marseille Medical 109(3): 197-200
Suzuki, J.; Taniguchi, S. 1983: 45X/46XY gonadal dysgenesis--a case report. Horumon to Rinsho. Clinical Endocrinology 31 Suppl: 57-59
Aubert, L.; Verdet, C.; Giraud, F.; Mattei, J.F. 1981: 45X/46XY/46XrY mosaic with banding and the Turner phenotype. Journal de Gynecologie Obstetrique et Biologie de la Reproduction 10(1): 57-60
Ford-Hutchinson, A.W.; Perkins, D.J. 1972: 46 Scandium metabolism; binding to metalloproteins in vivo and in vitro. Radiation Research 51(2): 244-248
Dewhurst, C.J.; Haines, R.M.; Lucas, M.; Delhanty, J. 1971: 46 XX karyotype in four tissues of a true hermaphrodite. Journal of Obstetrics and Gynaecology of the British Commonwealth 78(12): 1084-1086
Ausín, J.; Cavallé, L.; Márquez, M.; González-Merlo, J. 1980: 46 XY gonadal dysgenesis and dysgerminoma. Reproduccion 4(4): 349-356
Higashi, A.; Takada, S.; Iwao, T.; Takigawa, K.; Kakurai, S. 1968: 46 cases of hand tumors. Seikeigeka. Orthopedic Surgery 19(2): 112-114
Couture, F.; Tessier, Y. 1968: 46 episodes of cardiac resuscitation. Laval Medical 39(2): 109-112
Birnbacher, T. 1966: 46 years of experience in the conservative treatment of glaucoma. Klinische Monatsblatter für Augenheilkunde 148(4): 490-500
Kushner, D. 1974: Another use for Restodent. Journal of the Dental Association of South Africa 29(10): 597
Alfi, O.S.; Sanger, R.G.; Sweeny, A.E.; Donnell, G.N. 1974: 46, del (9) (22:), a new deletion syndrome. Birth Defects Original Article Series 10(8): 27-34
Crisalli, M.; Cuoco, C.; Gimelli, G.; Monteverde, R. 1981: 46, X, del (X) (p21) in a 14-year-old female with Turner signs, one streak and one normal ovary. Annales de Genetique 24(2): 114-116
Málková, J.; Chrz, R.; Motlík, K.; Stárka, L.; Kobilková, J.; Silinková-Málková, E. 1974: 46, XX gonadal dysgenesis and ovarian hypoplasia. Humangenetik 23(3): 205-211
De Grouchy, J.; Lautmann, F. 1968: 46, XX, 1q-, 2q-, Dq+, 16q+ karyotype in a polymalformed child. Annales de Genetique 11(2): 129-131
Kojima, S.; Tonouchi, T.; Mimaya, J.; Yokochi, T. 1984: 46, XX, dir ins (2;11)(q11;q13q23) in an infant with acute monoblastic leukemia. Japanese Journal of Clinical Hematology 25(8): 1260-1265
Van den Berghe, H.; Fryns, J.P.; Devos, F. 1973: 46, XXip karyotype in a woman with normal stature and gonadal dysgenesis without other congenital anomalies. Humangenetik 20(2): 163-166
Gardner, L.I.; Assemany, S.R.; Neu, R.L. 1970: 46, XY female: anti-androgenic effect of oral contraceptive?. Lancet 2(7674): 667-668
Honda, M.; Sato, E.; Munekata, S.; Sugawara, N.; Nagaura, Y. 1983: 46, XY hydatidiform mole--a case report. Nihon Sanka Fujinka Gakkai Zasshi 35(4): 595-598
Gardner, H.A. 1980: 46, XY lung adenocarcinoma in a 46, XX female patient. Acta Cytologica 24(4): 366
Zhukovskiĭ, M.A.; Dzenis, I.G. 1973: 46, XY, t(Dq--;Cp+?) karyotype in a child with testicular feminization syndrome. Voprosy Okhrany Materinstva i Detstva 18(12): 54-57
Gaál, M.; Tóth, A.; Bösze, P.; László, J. 1984: 46,X,i(Xq)/45,X mosaicism with gonadal dysgenesis associated with 21p-. Clinical Genetics 25(1): 79-83
Ansari, A.H.; Blair, J.D.; Doshi, N.S. 1973: 46,XX Turner's syndrome. American Journal of Obstetrics and Gynecology 116(3): 415-422
Tomasić, V.; Sepcić, J.; Kruzić, M.; Ledić, P.; Cuk, S.; Juranić, K. 1970: 46,XX chromosomal constitution in human ambigonadal hermaphrodite. Acta Geneticae Medicae et Gemellologiae 19(3): 425-430
Medina, M.; Kofman-Alfaro, S.; Pérez-Palacios, G. 1982: 46,XX gonadal absence: a variant of the XX pure gonadal dysgenesis?. Acta Endocrinologica 99(4): 585-587
Riggall, F.C.; Cantor, B. 1980: 46,XX hernia uterus inguinale and vaginal agenesis. Obstetrics and Gynecology 56(2): 265-266
Koulischer, L.; Gillerot, Y.; Richard, J. 1980: 46,XX,r(18), + mar karyotype in the niece of a leukemic patient with trisomy 21 and cri du chat chromosome. Annales de Genetique 23(4): 228-231
Schoenle, E.; Schmid, W.; Schinzel, A.; Mahler, M.; Ritter, M.; Schenker, T.; Metaxas, M.; Froesch, P.; Froesch, E.R. 1983: 46,XX/46,XY chimerism in a phenotypically normal man. Human Genetics 64(1): 86-89
Hunter, A.; Brierley, K.; Tomkins, D. 1982: 46,XX/46XY chromosome complement in amniotic fluid cell culture followed by the birth of a normal female child. Prenatal Diagnosis 2(2): 127-131
Sinnecker, G.; Willig, R.P.; Stahnke, N.; Braendle, W. 1982: 46,XY pure gonadal dysgenesis (Swyer's-syndrome). Clinical and endocrinological findings. Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 130(10): 795-797
Doty, D.W.; Gruber, J.S.; Wolf, G.C.; Winslow, R.C. 1980: 46,XY pure gonadal dysgenesis: report of 2 unusual cases. Obstetrics and Gynecology 55(3 Suppl): 61S-65S
Atkins, L.; Feingold, M. 1969: 46,XY,21qi-46,XY,21p- mosaicism in a child with Down's syndrome. Journal of Medical Genetics 6(2): 206-208
Chaudhuri, A.; Basu, S.N.; Chatterjee, M. 1970: 46,XY,G-, t(Gq Gq)+karyotype in a mongol. Indian Journal of Pediatrics 37(272): 469-473
Sijmons, R.H.; Sikkema-Raddatz, B.; Kloosterman, M.D.; Briet, J.W.; De Jong, B.; Leschot, N.J. 1995: 46,XY,dup(10q) in direct CVS preparation and mosaic 48,XXXY,dup(10q) in CVS long-term culture and fetal tissue. Prenatal Diagnosis 15(3): 285-290
Gardó, S.; Papp, Z.; Walawska, J. 1972: 46,XY--47,XY, 18+ mosaicism with a 23-year survival. Humangenetik 15(4): 357
Giraud, F.; Hartung, M.; Mattei, J.F.; Passeron, P.; Coignet, J. 1971: 46,XY-45,X mosaicism and 18p- deletion. Annales de Genetique 14(1): 59-62
Oikawa, K.; Kajii, T.; Shimba, H.; Sasaki, M. 1969: 46,XY-47,XY,C+ mosaicism in a male infant with multiple anomalies. Annales de Genetique 12(2): 102-106
Casey, P.A.; Clark, C.E.; Cowell, H.R. 1981: 46,XY/48,XXY, +8 in a male with clinical and dermatoglyphic features of mosaic trisomy 8 syndrome. Clinical Genetics 20(1): 60-63
Grace, H.J.; Ally, F.E.; Paruk, M.A. 1972: 46,Xinv(Yp+q-) in four generations of an Indian family. Journal of Medical Genetics 9(3): 293-297
Aritaki, S.; Someya, H.; Ogihara, M.; Ushio, M.; Matsuno, T. 1983: 46,x,t(x;15)(q21;q22) gonadal dysgenesis. Horumon to Rinsho. Clinical Endocrinology 31 Suppl: 59-62
Camacho, J.R.; Prakash, U.B. 1995: 46-year-old man with chronic hemoptysis. Mayo Clinic Proceedings 70(1): 83-86
Permanyer Miralda, C.; Bombi, J.A. 1983: 46-year-old woman with pericarditis and heart failure. Medicina Clinica 81(12): 531-539
Wedell, J. 1967: 46. on the clinical picture and pathology of recurrent, chronic peptic ulcer of the jejunum as a symptom of the Zollinger-Ellison syndrome. Langenbecks Archiv für Chirurgie 319: 289-300
Saito, T. 1973: 46. the resistance and capacitance at the initial and maximum transition by the half sine wave. Nihon Seirigaku Zasshi. Journal of the Physiological Society of Japan 35(8): 400
Kirkels, V.G.; Blankenborg, G.J.; Kock, L.I. 1970: 46XX-45X mosaicism in a patient with primary amenorrhea. Nederlandsch Tijdschrift Voor Verloskunde en Gynaecologie 70(2): 120-126
Brahmadathan, K.N.; Pandian, R.; Koshi, G. 1995: Long-term preservation of streptococci. Indian Journal of Medical Research 101(5): 64-65
Anonymous 1966: 46th annual report of the Council on Education, American Podiatry Association. Journal of the American Podiatry Association 56(2): 74-81
Anderson, J.J.; Crackel, W.C. 1971: 47 CA turnover of a readily exchangeable calcium pool in pregnant and lactating cows. Clinical Orthopaedics and Related Research 78: 311-313
Tomita, A.; Takatsuki, K.; Imagawa, T.; Uchikawa, T.; Fujita, T. 1974: 47 Ca kinetic studies on metabolic bone diseases. Kaku Igaku. Japanese Journal of Nuclear Medicine 11(2): 87-95
Tomita, A.; Fujita, T.; Takatsuki, K.; Shiono, M.; Yamauchi, N. 1971: 47 Ca kinetic study and vitamin K 2 in postmenopausal osteoporosis. Horumon to Rinsho. Clinical Endocrinology 19(9): 731-736
Whelton, M.J.; Kehayoglou, A.K.; Agnew, J.E.; Turnberg, L.A.; Sherlock, S. 1971: 47 Calcium abosrption in parenchymatous and biliary liver disease. Gut 12(12): 978-983
Malvaux, P.; van den Berghe, H.; de Visscher, M. 1967: 47 XXX karyotype in a phenotypically normal 22-year-old girl. Annales d'Endocrinologie 28(1): 146-147
Ságodi, L.; Kovács, H.; Vincze, J.; Vissy, A. 1984: 47 XXY karyotype with intersexual external genitalia. Orvosi Hetilap 125(1): 27-29
Ratcliffe, S.G.; Tierney, I.R. 1982: 47 XXY males and handedness. Lancet 2(8300): 716
Tosoni Dalai, J. 1972: 47 XYY men. Minerva Medica 63(86): 4724-4725
Dinno, N.D.; Silvey, G.L.; Weisskopf, B. 1974: 47, XY, t(9pplus;11qplus) in a mlae infant with multiple malformations. Clinical Genetics 6(2): 125-131
Borgaonkar, D.S. 1969: 47, XYY bibliography. Annales de Genetique 12(1): 67-70
Field, M.A.; Faed, M.J. 1974: 47, XYY chromosome constitution, physical growth and psychological disturbance. a case study. Journal of Child Psychology and Psychiatry and Allied Disciplines 15(4): 323-327
Boczkowski, K. 1969: 47, XYY karyotype in a eunuchoida female. Ginekologia Polska 40(6): 703-709
Geneix, A.; Janny, L.; Périssel, B.; Hermabessière, J.; Loubier, E.; Malet, P. 1983: 47,X,i(Xq), y karyotype. a new case. Pathologica 75(1037): 425-428
Neu, R.L.; Assemany, S.R.; Gardner, L.I. 1971: 47,XX,13+ with Snodgrass phenotype II. Are different chromosomes associated with two clinical varieties of D-trisomy?. Journal of Medical Genetics 8(2): 179-180
Bricarelli, F.D.; Gimelli, F.; Borrone, C. 1971: 47,XX,18+-46,XX-45,XX,18- mosaicism in a child with Edward's syndrome. Annales de Genetique 14(3): 229-233
Bigozzi, U.; Simoni, G.; Montali, E.; Dalpra, L.; Rossella, F.; Piazzini, M.; Borghi, A. 1980: 47,XXX chromosome constitution in a male. Journal of Medical Genetics 17(1): 62-66
Luciani, J.M.; Stahl, A.; Jubelin, J.; Simonin, R. 1970: 47,XXY Klinefelter's syndrome and familial marker chromosomes (double satellite on a chromosome of group D). La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 46(40): 2524-2528
Nistal, M.; Paniagua, R.; Abaurrea, M.A.; Pallardo, L.F. 1980: 47,XXY Klinefelter's syndrome with low FSH and LH levels and absence of Leydig cells. Andrologia 12(5): 426-433
Kucheria, K.; Kumar, V. 1983: 47,XXY chromosome pattern and variable phenotypes. Journal of the Association of Physicians of India 31(7): 429-432
Alvesalo, L.; Portin, P. 1980: 47,XXY males: sex chromosomes and tooth size. American Journal of Human Genetics 32(6): 955-959
Kardon, N.B.; Beratis, N.G.; Hsu, L.Y.; Moloshok, R.E.; Hirschhorn, K. 1971: 47,XXY-48,XXXY-49,XXXXY mosaicism in a 4-year-old child. American Journal of Diseases of Children 122(2): 160-162
Pufke, S. 1969: 47,XYY syndrome tallness and criminality. Arztliche Forschung 23(2): 74-85
Borgaonkar, D.S.; Unger, W.M.; Moore, S.M.; Crofton, T.A. 1972: 47,XYY syndrome, height and institutionalization of juvenile delinquents. British Journal of Psychiatry: the Journal of Mental Science 120(558): 549-550
Baccichetti, C.; D'Elia, R.; Tenconi, R. 1968: 47-48 mosaicism in newborn with trisomy D. Lancet 2(7583): 1397
Geissler, R.G.; Ganser, A.; Hübner, K.; Hör, G.; Hoelzer, D. 1995: 47-year-old patient with pulmonary hypertension, anemia and thrombocytopenia. Der Internist 36(4): 385-388
Turunen, M. 1967: 47. Afferent loop syndrome. Langenbecks Archiv für Chirurgie 319: 300-302
Miyazaki, S.; Sasaki, S.; Omori, H. 1973: 47. Excitability in egg cell membrane of the starfish. Nihon Seirigaku Zasshi. Journal of the Physiological Society of Japan 35(8): 400-401
Agnew, J.E. 1970: 47Ca absorption studies with a single crystal whole-body counter. British Journal of Radiology 43(508): 285
Harris, O.D.; Philip, H.M.; Cooke, W.T.; Pover, W.F. 1970: 47Ca studies in adult coeliac disease and other gastrointestinal conditions with particular reference to osteomalacia. Scandinavian Journal of Gastroenterology 5(3): 169-175
Ambazhagan, T.K. 1972: 47th All-India Medical Conference. Inaugural address. Journal of the Indian Medical Association 58(9): 317-320
Subramanyam, R. 1972: 47th All-India Medical Conference. Welcome address. Journal of the Indian Medical Association 58(9): 314-316
Anonymous 1967: 47th annual report of the Council on Education, American Podiatry Association. Journal of the American Podiatry Association 57(1): 25-33
Walbaum, R.; Vandevelde-Staquet, M.F.; Lefebvre, C.; Gnamey, D.K.; Delattre, B.; Leconte, D. 1973: 48 XXXX syndrome in an infant. Journal de Genetique Humaine 21(1): 43-56
Horowitz, L. 1983: 48 days of fever, pain in a 'healthy' old man. Hospital Practice 18(3): 61-62
Zhukauskas, G.I.; Kleĭza, V.I. 1982: 48 hour perfusion-less kidney preservation. Vestnik Khirurgii Imeni I. I. Grekova 129(7): 108-111
Larget-Piet, L.; Pignier, J.; Berthelot, J.; Ayache, P.; Bourdon, P.; Larget-Piet, A. 1972: 48, XXXX syndrome in a 5-year-old child. Pediatrie 27(4): 433-443
Lejeune, J.; Abonyi, D. 1968: 48, XXXX syndrome in a fourteen year old girl. Annales de Genetique 11(2): 117-119
De Grouchy, J.; Brissaud, H.E.; Richardet, J.M.; Repéssé, G.; Sanger, R.; Race, R.R.; Salmon, C.; Salmon, D. 1968: 48, XXXX syndrome in a six year old child. Abnormal transmission of group Xg. Annales de Genetique 11(2): 120-124
Rethoré, M.O.; Saraux, H.; Prieur, M.; Dutrillaux, B.; Meer, J.J.; Lejeune, J. 1972: 48, XXY, +21 syndrome and retinoblastoma. Archives Francaises de Pediatrie 29(5): 533-538
Yamamoto, K.; Mizumoto, T.; Ohkawara, A.; Takamura, T.; Okuno, A.; Shimomura, Y. 1981: 48, XXYY Klinefelter's syndrome with recurrent leg ulcer. Nihon Hifuka Gakkai Zasshi. Japanese Journal of Dermatology 91(7): 717-722
Madahar, D.P.; Dosik, H.; Wexler, I. 1974: 48,XXX, plus 18 double trisomy. Journal of Medical Genetics 11(3): 309-311
Borzani, M.; Adamoli, L.; Longhi, R.; Nocera, G.; Tibiletti, M.G. 1982: 48,XXXX syndrome in a 1-year-old girl. Minerva Pediatrica 34(13-14): 621-626
Bamatter, F.; Klein, D.; Tabibian, Y.; Tajmirova, O.; Boreux, G. 1969: 48,XXXY constitution in a 7-month-old infant, whose father has chromosome breaks. Archiv der Julius Klaus-Stiftung für Vererbungsforschung Sozialanthropologie und Rassenhygiene 44(3-4): Suppl: 64-68
Severi, F.; Colombo, A.; Svilokos, N.; Lo Curto, F.; Zuffardi, O. 1974: 48,XXXY/49,XXXXY Mosaicism in a 4 month old infant. Padiatrie und Padologie 9(1): 34-39
Bargman, G.J.; Neu, R.L.; Powers, H.O.; Gardner, L.I. 1970: 48,XY,21+, mar+mat: a case of trisomy 21 associated with an inherited small marker chromosome. Journal of Medical Genetics 7(1): 99-100
Crolla, J.A.; Machin, G.A. 1980: 48,XYY,+13 karyotype in a liveborn infant. Clinical Genetics 17(1): 31-34
Schoepflin, G.S.; Centerwall, W.R. 1972: 48,XYYY: a new syndrome?. Journal of Medical Genetics 9(3): 356-360
Grundmann, R.; Landes, T.; Pichlmaier, H. 1972: 48- to 72-hour canine kidney preservation by means of hypothermic non-pulsatile perfusion. Klinische Wochenschrift 50(24): 1141-1143
Dreikorn, K.; Horsch, R.; Röhl, L. 1980: 48- to 96-hour preservation of canine kidneys by initial perfusion and hypothermic storage using the Euro-Collins solution. European Urology 6(4): 221-224
Williams, M.; Hole, D.J.; Murdoch, R.W.; Ogden, A.C.; Hargreave, T.B. 1980: 48-hour cephradine and post-prostatectomy bacteriuria. British Journal of Urology 52(4): 311-315
Lerer, B.; Birmacher, B.; Ebstein, R.P.; Belmaker, R.H. 1980: 48-hour depressive cycling induced by antidepressant. British Journal of Psychiatry: the Journal of Mental Science 137: 183-185
Kreis, H.; Lacombe, M.; Ciancioni, C.; Marinov, V. 1972: 48-hour kidney preservation (initial perfusion with potassium and magnesium-rich solution). Revue Europeenne d'Etudes Cliniques et Biologiques. European Journal of Clinical and Biological Research 17(2): 192-196
Liu, W.P.; Humphries, A.L.; Stoddard, L.D.; Moretz, W.H. 1970: 48-hour kidney storage. Lancet 2(7669): 423
Williams, B. 1968: 48-hour maternity discharge--good or bad?. Nursing Mirror and Midwives Journal 127(15): 33-35
Lokkegaard, H.; Gyrd-Hansen, N.; Hansen, R.I.; Hasselager, E.; Nerstrom, B.; Rasmussen, F. 1972: 48-hour preservation of pig kidneys using continuous hypothermic plasma perfusion. Effect and complications. Acta Medica Scandinavica 192(4): 243-250
Wehr, T.A.; Goodwin, F.K.; Wirz-Justice, A.; Breitmaier, J.; Craig, C. 1982: 48-hour sleep-wake cycles in manic-depressive illness: naturalistic observations and sleep deprivation experiments. Archives of General Psychiatry 39(5): 559-565
Liu, W.P.; Humphries, A.L.; Russell, R.; Stoddard, L.D.; Moretz, W.H. 1971: 48-hour storage of canine kidneys after brief perfusion with Collins' solution. Annals of Surgery 173(5): 748-757
Sapkas, A. 1967: 48. a new technic for stump closure in penetrating duodenal ulcer. Langenbecks Archiv für Chirurgie 319: 302-306
Takeuchi, H.; Mori, A.; Kosaka, M. 1973: 48. on the identified molluscan giant neurone sensitive to serotonin and dopamine (Achatina fulica Ferussac). Nihon Seirigaku Zasshi. Journal of the Physiological Society of Japan 35(8): 401
Lourides, O.; Demetriou, N.; Lascaris, G.; Drikos, G. 1971: 481 cases of aphthous ulcers of the oral mucosa. Odontiatrike 5: 235-239
Cardon, J.P. 1973: 49 cases of azoospermia and oligospermia. Treatment with human menopausal gonadotropin. Journal de Gynecologie Obstetrique et Biologie de la Reproduction 2(2): 177-187
Wu, S.H. 1984: 49 cases of cerebral malaria in the Sudan. Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2(4): 256
Caldarola, L.; Badellino, F.; Calderini, P.; Cacciari, P.; Santoro, L.; Fariello, R. 1973: 49 interventions using the Wertheim-Meigs method in carcinoma of the uterine cervix. Il Cancro 26(2): 113-119
Larget-Piet, L.; Rivron, J.; Baillif, P.; Dugay, J.; Emerit, I.; Larget-Piet, A.; Berthelot, J. 1972: 49, XXXXX syndrome in a 5-year-old girl. Annales de Genetique 15(2): 115-119
Rasore-Quartino, A. 1971: 49, XXXXY chromosome abnormality. Description of a case in the neonatal age. Minerva Pediatrica 23(33): 1380-1382
Morić-Petrović, S.; Laca, Z.; Marković, S.; Marković, V. 1973: 49, XXXXY karyotype in mentally retarded boy. Journal of Mental Deficiency Research 17(1): 73-80
Fragoso, R.; Hernandez, A.; Plascencia, M.L.; Nazara, Z.; Martinez y Martinez, R.; Cantu, J.M. 1982: 49,XXXXX syndrome. Annales de Genetique 25(3): 145-148
Hayek, A.; Riccardi, V.; Atkins, L.; Hendren, H. 1971: 49,XXXXY chromossomal anomaly in a neonate. Journal of Medical Genetics 8(2): 220-221
Wiśniewski, L.; Krajewska-Walasek, M.; Lech, H.; Mospinek, M. 1980: 49,XXXXY syndrome in a 5-year-old boy. Pediatria Polska 55(1): 81-86
Szemere, G.; Szörényi, A.H.; László, A.; Bodrogi, T. 1983: 49,XXXXY syndrome with signs of precocious puberty. Orvosi Hetilap 124(1): 25-27
Webb, G.C.; Krumins, E.J.; Leversha, M.A.; Ford, G.W. 1984: 49,XXYY, +18 in a liveborn male. Journal of Medical Genetics 21(3): 232
Yai, H. 1973: 49. Effects of some blocking agents on acetylcholine response of snail ganglion cell. Nihon Seirigaku Zasshi. Journal of the Physiological Society of Japan 35(8): 401-402
Lindenschmidt, T.O.; Schwabe, G. 1967: 49. Ulcus carcinoma of the stomach. Clinical experience with 156 patients. Langenbecks Archiv für Chirurgie 319: 306-309
Boulvin, R.; Esphahani, A.; Zadeh; Tavakoli, A. 1969: 494 cases of acute volvulus of the colon. Memoires. Academie de Chirurgie 95(16): 467-471
Kundu, S.; Ghosh, S. 1972: 4:4 diacetyl-diamino-diphenyl sulphone in the treatment of leprosy. Bulletin of the Calcutta School of Tropical Medicine 20(2): 30-31
Morse, H.G.; Heideman, R.; Hays, T.; Robinson, A. 1982: 4;11 translocation in acute lymphoblastic leukemia: a specific syndrome. Cancer Genetics and Cytogenetics 7(2): 165-172
Holmstrom, M.; McGregor, D.B.; Willins, M.J.; Cuthbert, J.A.; Carr, S. 1982: 4CMB, 4HMB and BC evaluated by the micronucleus test using a multiple sampling method. Mutation Research 100(1-4): 357-359
Whalley, H.E.; Bootman, J.; Rees, R. 1982: 4CMB: investigation of activity in a mouse micronucleus test. Mutation Research 100(1-4): 361-364
Taylor, J.; MacDonald, T.T.; Spencer, J. 1995: 4D5.4, a monoclonal antibody which recognizes cells in inflamed human intestine. Advances in Experimental Medicine and Biology 371b: 1331-1332
Vega, S.; Gil, M.S.; Darias, V.; Sánchez Mateo, C.C.; Expósito, M.A.; Tello, M.L.; Albertos, L.M. 1994: 4H-pyrrolo[1,2-a]thieno[3,2-f] and 4H-pyrrolo[1,2-a]thieno-[2,3-f][1,4]diazepines: synthesis and pharmacological evaluation. Archiv der Pharmazie 327(11): 721-728
Fukuda, A.; Gilvarg, G.; Lewis, J.C. 1969: 4HPyran-2,6-dicarboxylate as a substitute for dipicolinate in the spolation of Bacillus megaterium. Journal of Biological Chemistry 244(20): 5636-5643
Lindquist, T.D.; Ingoglia, N.A.; Gould, R.M. 1981: 4S RNA is transported axonally in normal and regenerating axons of the sciatic nerves of rats. Brain Research 230(1-2): 181-194
Pljusnin, A.Z.; Vvedenskaya, I.O. 1983: 4S component of influenza virion RNA represented by a set of tRNAs. Virologie 34(1): 41-45
Zeller, E.A.; Gärtner, B.; Hemmerich, P. 1972: 4a,5-Cycloaddiction reactions of acetylenic compounds at the flavoquinone nucleus as mechanisms of flavoprotein inhibitions. Zeitschrift für Naturforschung. Teil B. Anorganische Chemie Organische Chemie Biochemie Biophysik Biologie 27(9): 1050-1052
Welch, W.M.; Ewing, F.E.; Harbert, C.A.; Weissman, A.; Koe, B.K. 1980: 4a,9b-trans-8-Fluoro-5-(4-fluorophenyl)-2-[4-(4-fluorophenyl)-4-hydroxybutyl]-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole hydrochloride, a new potent neuroleptic. Journal of Medicinal Chemistry 23(8): 949-952
Pelc, B. 1974: 4alpha-Hydroxycholecalciferol and an attempted synthesis of its 4beta-hydroxy-epimer. Journal of the Chemical Society. Perkin Transactions 12: 1436-1438
Borgioli, M.; Baquis, G. 1970: 4n-buthoxy-beta(I-piperidil) propiophenone chlorhydrate in the local anesthesia in ophthalmoloy and its antimicrobial properties. Annali di Ottalmologia E Clinica Oculistica 96(4): 181-211
Magill, H.L.; Shackelford, G.D.; McAlister, W.H.; Graviss, E.R. 1980: 4p- (Wolf-Hirschhorn) syndrome. Ajr. American Journal of Roentgenology 135(2): 283-288
Stoll, C.; Pennerath, A.; Lausecker, C. 1981: 4p- syndrome in a girl with translocation t(1;4)(q11;p16)mat. Human Genetics 56(3): 413-415
Zergollern, L.; Begović, D. 1984: 4q deletion syndrome (de novo). Acta Medica Iugoslavica 38(2): 133-138
Ohdama, S.; Yoshizawa, Y.; Kubota, T.; Aoki, N. 1994: Plasma thrombomodulin as an indicator of thromboembolic disease in systemic lupus erythematosus. International Journal of Cardiology 47(1 Suppl): S1-S6
Friou, G.J.; Friou, G.J. 1994: Setting the scene: a historical and personal view of immunologic diseases, autoimmunity and ANA. Clinical and Experimental Rheumatology 12(Suppl 11): S23-S25
Reichard, P. 1968: 4th FEBS Meeting's Plenary Lecture. The biosynthesis of deoxyribonucleotides. European Journal of Biochemistry 3(3): 259-266
Rehfeldt, M. 1968: 4th German pharmacists day and its conclusions for speciality pharmacy in united health organizations of the Königs Wusterhausen district. Pharmazeutische Praxis 5: 108-111
Anonymous 1994: 4th International Conference on Narcolepsy. Paris, October 17-18, 1993. Proceedings. Sleep 17(8 Suppl): S1-115
Braun, S.; Tolkovsky, A.M.; Steer, M.L.; Lester, H.A.; Levitzki, A. 1982: Activation and inhibition of adenylate cyclase by hormones. Biochemical Society Transactions 10(6): 496-498
Jacotot, B. 1994: Atherosclerosis, a multifactor lesion justifying multirisk care. Atherosclerosis 110 Suppl: S1-S2
Bermingham, J.; Haskell, S.H. 1971: 4th Internationall Seminar on Special Education. Developmental Medicine and Child Neurology 13(4): 536-538
Anonymous 1981: 4th National Congress: Current medical and social status and trends in underwater and hyperbaric medicine. Naples, 24-26 October 1980. Minerva Medica 72(52): 3617-3627
Anonymous 1972: 4th National Survey charts patterns of practice. 38 per cent of dentists reported as "too busy". Journal of the Canadian Dental Association 38(6): 205
Dal Fabbro, G.; Frugoni, G. 1981: Diagnosis and methodological principles of clinical pathology. i. Minerva Medica 72(42): 2853-2864
Somolinos-D'Ardois, G. 1971: 4th centennial of the 1st medical book printed in America. 3. Comments. Gaceta Medica de Mexico 101(3): 316-318
De la Torre-Villar, E. 1971: 4th centennial of the 1st medical book printed in America. I. Importance of the book in Mexican culture. Gaceta Medica de Mexico 101(3): 303-310
Fernández del Castillo, F. 1971: 4th centennial of the 1st medical book printed in America. II. The Opera Medicinalia by Dr. Francisco Bravo (September 12, 1570). Gaceta Medica de Mexico 101(3): 310-315
Del Castillo, F.F.; d' Somolinos Ardois, G. 1970: 4th centennial of the first medical book in America. La Prensa Medica Mexicana 35(1): 34-35
Boccanera, L.; Laus, M. 1983: 4th generation computed axial tomography in non-traumatic vertebral pathology (study of 40 cases). Archivio "putti" di Chirurgia Degli Organi di Movimento 33: 23-34
Schmidt, B. 1974: 4th list of disinfectants tested for bactericidal properties following the "instructions for the testing of chemical disinfectants" by the German Society of Hygiene und Mikrobiology. Status as of January 1, 1974. Das Offentliche Gesundheitswesen 36(3): 210-234
Anonymous 1973: 4th million persons registered. Sairaanhoitaja. Sjukskoterskan 49(14): 18-20
Anonymous 1973: 4th opinion of the German Society for Industrial Safety, Inc. on the scope, qualification and position of the factory medical officer with reference to the draft on a "law on factory medical officers and specialists for industrial safety". Zentralblatt für Arbeitsmedizin und Arbeitsschutz 23(10): 305-307
Burén, A.; Dahlgren, H.; Lücke, B.; Wretmark, G. 1971: 4th report from Birgitta Hospital: even understanding and encouragement after so much criticism. Lakartidningen 68(17): 1962-1963
Villalobos, J.J.; García, M.P.; Campos, A.; Maqueo, M.; Ciklik, E. 1982: 4th report of the Study Group on Cancer of the Digestive System. Gaceta Medica de Mexico 118(10): 419-426
Anonymous 1969: 4th seminar on control of drugs and food in Central America and Panama. Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau 66(1): 83
Kauffmann, G.W. 1966: Community care of the so-called inactive primary tuberculosis. Zeitschrift für Tuberkulose und Erkrankungen der Thoraxorgane 125(3): 181-192
Fontaine, R.; Kieny, R. 1965: 4th success obtained with pulmonary embolectomy, this time under extra-corporeal circulation. Memoires. Academie de Chirurgie 91(28): 908-911
Stefanko, S.; Retinger, M.; Glowacki, J. 1972: 4th ventricle epidermoid with an unusual course. Neurologia i Neurochirurgia Polska 6(1): 145-148
Hoch-Ligeti, C. 1972: 5 -3 -Hydroxysteroid dehydrogenase activity in human adrenal cortical adenomas. Archives of Pathology 93(5): 467-472
Pohanka, D.G.; Smiciklas-Wright, H.; Pike, R.L. 1973: 5 -3 -Hydroxysteroid dehydrogenase activity in the adrenal cortex of the sodium-restricted pregnant rat. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 142(4): 1092-1096
Bulger, W.H.; Stohs, S.J. 1973: 5 -Hydroxydigitoxigenin--a metabolite of digitoxigenin by rabbit liver homogenates. Biochemical Pharmacology 22(14): 1745-1750
Ghraf, R.; Lax, E.R.; Hoff, H.G.; Pfaender, B.I.; Schriefers, H. 1972: 5 -Metabolites of testosterone: modus, sex specificity and age dependence of their formation in the rat liver. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 353(10): 1517-1518
Matsumoto, K.; Yamada, M. 1973: 5 -Reduction of testosterone in vitro by rat seminiferous tubules and whole testes at different stages of development. Endocrinology 93(1): 253-255
Subbiah, M.T.; Kottke, B.A.; Carlo, I.A. 1971: 5 -cholestan-3 -Ol: high concentration in testis of White Carneau pigeon. Lipids 6(7): 517-519
Sanyal, M.K.; Todd, R.B. 1972: 5 -dihydroprogesterone influence on ovulation of prepuberal rats. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 141(2): 622-624
Alfheim, I.; Unhjem, O. 1971: 5 -dihydrotestosterone and the synthesis of RNA in the rat ventral prostate in vitro. Acta Endocrinologica 68(3): 567-575
Alfheim, I. 1973: 5 -dihydrotestosterone and the synthesis of RNA in the rat ventral prostate in vitro. II. Studies on the qualitative effect. Acta Endocrinologica 73(1): 189-195
Gibb, W.; Jeffery, J. 1972: 5 -dihydrotestosterone sulphate and cortisone reductase. Biochimica et Biophysica Acta 280(4): 646-651
Sheikh, Y.M.; Tursch, B.M.; Djerassi, C. 1972: 5 -pregn-9(11)-ene-3 ,6 -diol-20-one and 5 -cholesta-9(11),20(22)-diene-3 ,6 -diol-23-one. two novel steroids from the starfish Acanthaster planci. Journal of the American Chemical Society 94(9): 3278-3280
Tcholakian, R.K.; Eik-Nes, K.B. 1971: 5 -pregnenolone and testosterone in spermatic venous blood of anesthetized dogs. American Journal of Physiology 221(6): 1824-1826
Matsumoto, K.; Yamada, M.; Yasue, S. 1972: 5 -reduction of testosterone and biosynthesis of androgen in the germ cells of the testis of young rats. Horumon to Rinsho. Clinical Endocrinology 20(12): 1035-1043
Tsuji, M.; Takeyama, M.; Takatsuka, D.; Yabumoto, H.; Terada, N.; Matsumoto, K. 1984: 5 Alpha- and 5 beta-reductases for 4-ene-3-ketosteroids and 17 beta-ol-dehydrogenase in epididymis and testis of golden hamster during sexual development. Journal of Steroid Biochemistry 21(2): 179-183
Lee, W.H.; Lutsky, B.N.; chropfer, G.J. 1969: 5 Alpha-cholest-8(14)-en-3 beta-ol, a possible intermediate in the biosynthesis of cholesterol. Enzymatic conversion to cholesterol and isolation from rat skin. Journal of Biological Chemistry 244(20): 5440-5448
McGuire, L.; Bariso, C.D.; Van Petten, L.E.; Washington, C.L.; DaVanzo, J.P.; Willigan, D.A. 1973: 5 Alpha-dihydrotestosterone-induced changes in the rat prostate. Investigative Urology 11(2): 101-105
McKercher, G.; Chevalier, S.; Roberts, K.D.; Bleau, G.; Chapdelaine, A. 1984: 5 Alpha-reductase and 3 alpha-hydroxysteroid dehydrogenase activities in isolated canine prostatic epithelial cells. Journal of Steroid Biochemistry 21(5): 549-554
Okuda, K.; Takigawa, N.; Fukuba, R.; Kuwaki, T. 1969: 5 Beta-cholestane-3 alpha,7 alpha,12 alpha,26-tetrol:NAD+ oxidoreductase and 5 beta-cholestane-3 alpha,7 alpha,12 alpha-triol-26-al:NAD+ oxidoreductase in rat liver. Biochimica et Biophysica Acta 185(1): 1-8
Balthazart, J.; Ottinger, M.A. 1984: 5 Beta-reductase activity in the brain and cloacal gland of male and female embryos in the Japanese quail (Coturnix coturnix japonica). Journal of Endocrinology 102(1): 77-81
Bodson, J. 1966: 5 Cases of glomus tumors. Acta Oto-Rhino-Laryngologica Belgica 20(5): 577-588
Cetin, E.T.; Akbay, Z.; Maurin, J. 1965: 5 Cases of herpangina caused by different types of Coxsackievirus a group. Tip Fakultesi Mecmuasi 28(4): 427-432
Nagatani, T.; Miyamoto, H.; Nakajima, H.; Nagai, R.; Tobinai, T.; Minato, K.; Shimoyama, M. 1983: 5 Cases of immunoblastic lymphadenopathy (IBL)- like T cell lymphoma-a report on the clinical, histopathological and immunological investigations. Nihon Hifuka Gakkai Zasshi. Japanese Journal of Dermatology 93(4): 421-431
Matsuzaki, A.; Kobayashi, A.; Misuyasu, M.; Morooka, M.; Honda, K. 1969: 5 Cases of neuralgic amyotrophy with neuroparalysis of the anterior interosseous nerve as a main symptom. Seikeigeka. Orthopedic Surgery 20(8): 916-923
Riedi, J. 1972: 5 Cases of soft tissue sarcomas in infants and children. Schweizerische Rundschau für Medizin Praxis 61(35): 1091-1097
Okamoto, O.; Okamoto, H. 1966: 5 Cases of upper canines erupting at the region adjacent to the 1st molars. Shika Gakuho. Dental Science Reports 66(6): 622-626
Pakkala, K. 1968: 5 Decades ago. SAIRAANHOITAJA. Sjukskoterskan 44(4): 160-163 Passim
Kint, A.; Kint, R.T.; Schuddinck, L. 1972: 5 FU in the treatment of Xeroderma pigmentosum. Archives Belges de Dermatologie et de Syphiligraphie 28(3): 263-266
Jameson, M.; Thompson, P.; Hastie, B. 1995: 5 Fluorouracil cardiotoxicity. New Zealand Medical Journal 108(992): 21
Siafarikas, K. 1974: 5 Hydroxyindol-acetic (5-hiaa) in the urine of mature newborn children with and without phototherapy. Klinische Padiatrie 186(3): 243-244
Audier, M.; Serradimigni, A.; Salvini, A.; Pertus, P. 1972: 5 Personal cases of cardiomyopathies in children and adolescents. Pediatrie 27(1): 77-80
Feo, M. 1972: 5 Prototheca strains of human origin. Mycopathologia et Mycologia Applicata 46(1): 53-59
Brown, D.D.; Sugimoto, K. 1973: 5 S DNAs of Xenopus laevis and Xenopus mulleri: evolution of a gene family. Journal of Molecular Biology 78(3): 397-415
Saarma, M.; Metspalu, A.; Villems, R.; Ord, T.; Toots, I. 1981: 5 S RNA and 5.8 S RNA build up eukaryotic subribosomal domains active in tRNA binding. Febs Letters 136(2): 255-258
Monier, R.; Feunteun, J.; Forget, B.; Jordan, B.; Reynier, M.; Varricchio, F. 1969: 5 S RNA and the assembly of bacterial ribosomes. Cold Spring Harbor Symposia on Quantitative Biology 34: 139-148
Metspalu, E.; Ustav, M.; Villems, R. 1983: 5 S RNA-protein complex is involved in ribosomal subunit association. Febs Letters 153(1): 125-127
Geroch, M.E.; Richards, E.G.; Davies, G.A. 1968: 5 S RNA. 1. Preparation and characterisation of highly purified 5 S RNA from Escherichia coli. European Journal of Biochemistry 6(3): 325-330
Andress, D.; Mousseron-Canet, M.; Raynal, F. 1973: 5 S estradiol receptor, acid protein of the nucleus and nucleoplasmic RNA polymerase in cow endometrium. Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences. Serie D: Sciences Naturelles 276(1): 97-99
Doolittle, W.F. 1981: 5 S ribosomal RNA genes and the Alui family: evolutionary and functional significance of a region of strong homology. Febs Letters 126(2): 147-149
Bronsch, T.; Gudowski, J. 1973: 5 Strontium scintigraphy of the pelvis. Radiobiologia Radiotherapia 14(5): 535-543
Dugacki, V. 1968: 5 Years of fierce struggles for the establishment of the School of Medicine in Zagreb (1886-1891). Lijecnicki Vjesnik 90(12): 1239-1258
Birkner, R.; Boeck, M. 1966: 5 Years of telecobalt irradiation of tumors of the female breast. Strahlentherapie 131(1): 79-90
Jennings, B.H.; Boudreau, S.M.; Braasch, B.; Garganta, C. 1982: 5 alpha, 6 alpha- and 5 beta, 6 beta-Dichloromethylene adducts of 3 beta-acetoxy-5-androsten-17-one. Steroids 39(4): 371-380
Meyer, D.J.; Ketterer, B. 1982: 5 alpha,6 alpha-Epoxy-cholestan-3 beta-ol (cholesterol alpha-oxide): a specific substrate for rat liver glutathione transferase B. Febs Letters 150(2): 499-502
Nakhla, A.M.; Ding, V.D.; Khan, M.S.; Romas, N.A.; Rhodes, L.; Smith, R.G.; Rosner, W. 1995: 5 alpha-Androstan-3 alpha,17 beta-diol is a hormone: stimulation of cAMP accumulation in human and dog prostate. Journal of Clinical Endocrinology and Metabolism 80(7): 2259-2262
Morfin, R.F.; Di Stefano, S.; Charles, J.F.; Floch, H.H. 1980: 5 alpha-Androstane-3 beta, 17 beta-diol and 5 alpha-androstane-3 beta, 7 alpha, 17 beta-triol in the human hyperplastic prostate. Journal of Steroid Biochemistry 12: 529-532
Loseva, L.A.; Degtiar, V.G.; Isachenkov, V.A. 1980: 5 alpha-Androstane-3 beta, 17 beta-diol in feedback between gonads and hypothalamo-pituitary system of male rats. Journal of Steroid Biochemistry 13(8): 939-944
Schroepfer, G.J.; Sherrill, B.C.; Wang, K.S.; Wilson, W.K.; Kisic, A.; Clarkson, T.B. 1984: 5 alpha-Cholest-8(14)-en-3 beta-ol-15-one lowers serum cholesterol and induces profound changes in the levels of lipoprotein cholesterol and apoproteins in monkeys fed a diet of moderate cholesterol content. Proceedings of the National Academy of Sciences of the United States of America 81(21): 6861-6865
Schroepfer, G.J.; Parish, E.J.; Kisic, A.; Jackson, E.M.; Farley, C.M.; Mott, G.E. 1982: 5 alpha-Cholest-8(14)-en-3 beta-ol-15-one, a potent inhibitor of sterol biosynthesis, lowers serum cholesterol and alters distributions of cholesterol in lipoproteins in baboons. Proceedings of the National Academy of Sciences of the United States of America 79(9): 3042-3046
Carroll, J.; Komanicky, P.; Melby, J.C. 1981: 5 alpha-Dihydro-11-deoxycorticosterone: effect on blood pressure in the rat. Steroids 37(1): 111-120
Mercier, L.; Valotaire, Y.; Jouan, P. 1980: 5 alpha-Dihydrotestosterone nuclear receptor and RNA polymerases activity in the male rat anterior pituitary (in vitro studies). Journal of Steroid Biochemistry 12: 355-359
Tobias, J.H.; Gallagher, A.; Chambers, T.J. 1994: 5 alpha-Dihydrotestosterone partially restores cancellous bone volume in osteopenic ovariectomized rats. American Journal of Physiology 267(6 Pt 1): E853-E859
Kopu, H. 1981: 5 alpha-Dihydrotestosterone-induced uteroglobin synthesis in rabbit uterus is not inhibited by antiandrogen administration but is prevented by estradiol. Biochimica et Biophysica Acta 654(2): 293-296
Savory, J.G.; May, D.; Reich, T.; La Casse, E.C.; Lakins, J.; Tenniswood, M.; Raymond, Y.; Haché, R.J.; Sikorska, M.; Lefebvre, Y.A. 1995: 5 alpha-Reductase type 1 is localized to the outer nuclear membrane. Molecular and Cellular Endocrinology 110(1-2): 137-147
Doering, C.H.; Gladue, B.A. 1982: 5 alpha-androstane-3 beta, 17 beta-diol binds to androgen and estrogen receptors without activating copulatory behavior in female rats. Pharmacology Biochemistry and Behavior 16(5): 837-840
Denef, C. 1983: 5 alpha-dihydrotestosterone formation and its functional significance in rat anterior pituitary, subpopulations of gonadotrophs and cell cultures. Journal of Steroid Biochemistry 19(1a): 235-239
Azoury, R.; Eyal, F.; Springer, C. 1982: 5 alpha-reductase activity in human fetal testis. International Journal of Biochemistry 14(7): 577-580
Djøseland, O.; Bruchovsky, N.; Rennie, P.S.; Otal, N.; Høglo, S. 1983: 5 alpha-reductase activity in stroma and epithelium of rat prostate and epididymis. a contribution to elucidation of the mechanism for development of hyperplastic growth of prostatic tissue. Acta Endocrinologica 103(2): 273-281
Corrall, R.J.; Wakelin, K.; O'Hare, J.P.; O'Brien, I.A.; Ishmail, A.A.; Honour, J. 1984: 5 alpha-reductase deficiency: diagnosis via abnormal plasma levels of reduced testosterone derivatives. Acta Endocrinologica 107(4): 538-543
Weisser, H.; Tunn, S.; Debus, M.; Krieg, M. 1994: 5 alpha-reductase inhibition by finasteride (Proscar) in epithelium and stroma of human benign prostatic hyperplasia. Steroids 59(11): 616-620
Schröder, F.H. 1994: 5 alpha-reductase inhibitors and prostatic disease. Clinical Endocrinology 41(2): 139-147
Stoner, E. 1994: 5 alpha-reductase inhibitors for the treatment of benign prostatic hyperplasia. Recent Progress in Hormone Research 49: 285-292
Yasue, S.; Yamada, M.; Mizutani, S.; Matsumoto, K. 1974: 5 alpha-reduction of testosterone in vitro by seminiferous tubules, prostate and muscle from immature rats. Endocrinologia Japonica 21(2): 161-166
Guivarc'h, M.; Loirat, P.; Stern, M.; Roullet-Audy, J.C. 1981: 5 atrial or caval perforations by a central venous catheter. Chirurgie; Memoires de l'Academie de Chirurgie 107(3): 256-257
Cheminot, R. 1983: 5 bandages in 1. Soins. Chirurgie 1983(30-31): 62-64
Tsuji, M.; Terada, N.; Sato, B.; Matsumoto, K. 1982: 5 beta- and 5 alpha-reductases for 4-ene-3-ketosteroids in golden hamster ovaries at different stages of development. Journal of Steroid Biochemistry 16(2): 207-213
Deviche, P.; Bottoni, L.; Balthazart, J. 1982: 5 beta-Dihydrotestosterone is weakly androgenic in the adult Japanese quail (Coturnix coturnix japonica). General and Comparative Endocrinology 48(4): 421-424
Jiang, Q.; Sebastian, A.; Archer, S.; Bidlack, J.M. 1994: 5 beta-Methyl-14 beta-(p-nitrocinnamoylamino)-7,8-dihydromorphinone and its corresponding N-cyclopropylmethyl analog, N-cyclopropylmethylnor-5 beta-methyl-14 beta-(p-nitrocinnamoylamino)- 7,8-dihydromorphinone: mu-selective irreversible opioid antagonists. Journal of Pharmacology and Experimental Therapeutics 268(3): 1107-1113
Jiang, Q.; Sebastian, A.; Archer, S.; Bidlack, J.M. 1993: 5 beta-Methyl-14 beta-(p-nitrocinnamoylamino)-7,8-dihydromorphinone: a long-lasting mu-opioid receptor antagonist devoid of agonist properties. European Journal of Pharmacology 230(1): 129-130
Schlinger, B.A.; Amur-Umarjee, S.; Campagnoni, A.T.; Arnold, A.P. 1995: 5 beta-reductase and other androgen-metabolizing enzymes in primary cultures of developing zebra finch telencephalon. Journal of Neuroendocrinology 7(3): 187-192
Korsova, T.L.; Segal', G.M. 1971: 5 beta-steroid reductase activity of the soluble fraction of rat liver. Biokhimiia 36(2): 253-257
D'Amico, D.; Lise, M.; Giron, G.; Pignatelli, M.G.; Biasiato, R. 1971: 5 case reports of emergency portacaval anastomosis. Acta Chirurgica Italica 27(4): 233-239
Ljunggren, B.; Strömblad, L.G.; Blennow, G.; Bynke, H. 1984: 5 case reports: Headache and brain tumor in children. Lakartidningen 81(18): 1828-1830
Hägg, E.; von Essen, C.; Liliequist, B.; Asplund, K. 1984: 5 case reports: Hypophyseal apoplexy--a noteworthy problem of differential diagnosis. Lakartidningen 81(43): 3937-3940
Miyazaki, Y.; Tsutsumi, H. 1966: 5 cases in 2 lineages of hereditary spinocerebellar ataxia. Naika. Internal Medicine 18(3): 570-576
Ogane, S.; Funayama, M.; Watanabe, M.; Kimura, A.; Kawamura, H. 1971: 5 cases of Hurler's and Hunter's syndromes. Seikeigeka. Orthopedic Surgery 22(2): 114-119
Bassleer, J.; Nautet, M.; Dargent, C. 1973: 5 cases of Isospora hominis in Belgium. Revue Medicale de Liege 28(8): 270-272
Morini, A. 1984: 5 cases of Legionella pneumopathy from various districts. Minerva Medica 75(34): 1968
Colette, C.; Eschbach, J.; Menetre, G.; Percher, P. 1966: 5 cases of Rokitansky-Kuster syndrome in Franche-Comté. Bulletin de la Federation des Societes de Gynecologie et Dobstetrique de Langue Francaise 18(2): 190-192
Yokoyama, Y.; Kono, T.; Ninomiya, H.; Ishikawa, T.; Iizuka, K. 1970: 5 cases of SLE (systemic lupus erythematodes with diagnostic difficulty). Nihon Rinsho. Japanese Journal of Clinical Medicine 28(5): 1602-1607
Mihalecz, M.; Novaszel, F. 1966: 5 cases of Wofatox poisoning at our hospital. Orvosi Hetilap 107(42): 1998-2000
Ratel, M.; Boucharlat, J.; Wolf, R.; Maître, A.; Ledru, J. 1974: 5 cases of acute catatonia with fatal development. Annales Medico-Psychologiques 1(3): 397-407
Ueki, Y.; Higo, O.; Takizawa, Y.; Amaki, I. 1970: 5 cases of acute leukemia beginning with hypoplastic form--biopsy of bone marrow tissue. Nihon Rinsho. Japanese Journal of Clinical Medicine 28(7): 1976-1981
Miguères, J.; Armengaud, M.; Layssol, M.; de Boissezon, J.F.; Colombies, P. 1969: 5 cases of agammaglobulinemia in adults and adolescents. Le Poumon et le Coeur 25(4): 399-410
Vendramin, M.L. 1974: 5 cases of arterial occlusion treated with streptase. Minerva Cardioangiologica 22(2): 127-133
Bracchetti, D.; Minuzzo, I.; Bonvicini, M.; Magnani, B. 1974: 5 cases of auricular arrhythmic disease. Bollettino Della Societa Italiana di Cardiologia 19(2): 137-141
Ando, H.; Akiyama, T.; Motoki, T.; Nakamura, K. 1970: 5 cases of breast cancer among patients in their 20's and sex chromatin counts. Gan no Rinsho. Japan Journal of Cancer Clinics 16(9): 943-946
Gredzhev, A.F.; Minin, V.V. 1967: 5 cases of calcification of the gall bladder. Vestnik Khirurgii Imeni I. I. Grekova 98(11): 124-125
Wangermez, C.; Chastrusse, L.; Dubecq, J.P.; Lesbats, G. 1968: 5 cases of cancer of the cervix and pregnancy. Bulletin de la Federation des Societes de Gynecologie et Dobstetrique de Langue Francaise 20(2): 148-149
Allain, Y.M.; Hochereau, Y.; Fornier, P.; Championnat, C. 1966: 5 cases of cancerous pulmonary lymphangitis noted in gynecology. Journal de Radiologie d'Electrologie et de Medecine Nucleaire 47(1): 41-46
Ascorbe Domínguez, A. 1969: 5 cases of carbon monoxide poisoning treated with hyperbaric oxygenation. Revista Espanola de Anestesiologia y Reanimacion 16(4): 542-544
Terao, A.; Okamoto, Y.; Kono, M. 1967: 5 cases of cervical myelopathy presenting interesting clinical courses. Iryo 21(5): 553-559
Torchinsky, J. 1983: 5 cases of cervicofacial actinomycoses. Revue de Stomatologie et de Chirurgie Maxillo-Faciale 84(1): 66
Krainik, C.; Cayla, J. 1983: 5 cases of chondrosarcoma. Review of the literature. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 59(10): 653-659
Kimura, H.; Takahara, N.; Hirata, K. 1969: 5 cases of chronic Brodie type local osteomyelitis. Seikeigeka. Orthopedic Surgery 20(4): 457-461
Troncoso, R.; Muñoz, M.A.; Almeyda, M.; Ogueta, D.; Díaz, M. 1967: 5 cases of chronic Chagasic myocarditis. Boletin Chileno de Parasitologia 22(1): 27-32
Shiono, M.; Kusakabe, Y.; Uehara, S.; Arai, T.; Nakamura, J. 1984: 5 cases of chronic desquamative gingivitis. Shikai Tenbo 63(6): 1183-1196
Kato, T.; Kanbara, H.; Sato, S.; Tanaka, I. 1968: 5 cases of clavicular fractures misdiagnosed as congenital myogenic torticollis. Seikeigeka. Orthopedic Surgery 19(9): 729-732
Wada, Y.; Satoh, T.; Kubo, M. 1995: 5 cases of clostridium difficile enteritis in infants. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 69(5): 608-614
Ollagnier, C.; Vallon, C. 1971: 5 cases of cold abscessed lymph nodes in the thyroid region. Lyon Medical 226(15): 303-308
Verger, P.; Bentegeat, J.; Mesnier, F.; Ballan, M.; Chateauneuf, P.; Rougeot, J.; Mingasson, F.; Guillard, J.M.; Palasset, J. 1965: 5 cases of congenital agammaglobulinemia in children, discovered in 3 families. Importance, in 2 cases, of polyarticular rheumatism attacks. Journal de Medecine de Bordeaux et du Sud-Ouest 142(11): 1829-1840
Gianotti, F. 1969: 5 cases of congenital bullous incontinentia pigmenti. Bulletin de la Societe Francaise de Dermatologie et de Syphiligraphie 76(3): 321-322
Sunada, T.; Teramoto, S.; Nakanishi, S.; Fujiwara, T.; Shirahige, K. 1971: 5 cases of congenital coronary artery fistula. Kyobu Geka. Japanese Journal of Thoracic Surgery 24(9): 643-649
Amano, H.; Nanbu, M.; Wada, I.; Sakita, R.; Ueyama, H.; Imai, Y.; Ueda, H. 1983: 5 cases of constitutional indocyanine green (ICG) excretory defect. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 72(8): 1074-1079
Deruty, R.; Jallade, S.; Fischer, G.; Dechaume, J.P. 1969: 5 cases of craniocerebral wounds caused by projectiles, 4 of them suicidal. Journal de Medecine de Lyon 50(172): 1311-1323
Mugnier, A.; Leger, A.; Schouker, M. 1970: 5 cases of dentinogenesis imperfecta. Revue de Stomatologie et de Chirurgie Maxillo-Faciale 71(6): 548-557
Longefait, H.; Hartung, L.; Barbe, A.; Lieutaud, R.; Serra, P. 1966: 5 cases of diffuse pleural tumors. Surgical aspects. Journal Francais de Medecine et Chirurgie Thoraciques 20(5): 507-534
Kumamoto, I.; Nomoto, M.; Yoshidome, H.; Osame, M.; Igata, A. 1984: 5 cases of dystonia with marked diurnal fluctuation and special reference to homovanillic acid in CSF. Rinsho Shinkeigaku 24(7): 697-702
Chassagnon, C.; Boisson, M.; Faguer, P. 1970: 5 cases of fatal hemorrhagic accidents during prolonged anticoagulant treatments. Journal de Medecine de Lyon 51(179): 409
Brabant, H.; Hanssens, P. 1970: 5 cases of gangrenous phlegmon of the floor of the mouth. Revue de Stomatologie et de Chirurgie Maxillo-Faciale 71(1): 87-98
Morineaud, J.P.; Gauchot, G.; Revil, H.; Thomas, J.; Sagnet, H.; Mafart, Y. 1970: 5 cases of hemoglobin E-thalassemia in South Vietnam. Medecine Tropicale: Revue du Corps de Sante Colonial 30(1): 109-113
Gérard, J. 1980: 5 cases of hyperprolactinemia. Review of the physiology of prolactin and its role in pathology. Revue Medicale de Liege 35(4): 98-112
Colonna, M.; Pesce Delfino, V.; Introna, F. 1982: 5 cases of identification established by televised superposition of photos of the face and the skull. Acta Medicinae Legalis et Socialis 32: 445-449
Paoli, F.; Brandigi, L. 1970: 5 cases of inhalation of talc. Minerva Pediatrica 22(35): 1772-1774
Tonooka, N.; Yamamoto, K.; Sugita, Y.; Onaya, T.; Takemura, Y. 1971: 5 cases of intrathoracic goiter. Naika. Internal Medicine 28(2): 354-357
Peycelon, R.; Correard, R.P.; Lesbros, F.; Mestrallet, G. 1970: 5 cases of leiomyosarcoma of the small intestine. Anatomoclinical and prognostic study. Lyon Chirurgical 66(6): 420-426
Motohashi, K. 1965: 5 cases of maxillary protrusion treated by Begg's technique. Nihon Kyosei Shika Gakkai Zasshi 24(1): 72-94
Fukuda, H.; Tanaka, H. 1965: 5 cases of meniscus ganglion. Seikeigeka. Orthopedic Surgery 16(12): 1068-1074
Maroteaux, P. 1970: 5 cases of microgeodic disease of phalanges of unknown etiology in infants. Annales de Radiologie 13(3): 229-236
Grigorov, G. 1965: 5 cases of mycetoma. Khirurgiia 18(5): 602-605
Valayer, J.; Alain, J.L. 1970: 5 cases of neonatal cysts of the ovary. Annales de Chirurgie Infantile 11(5): 313-317
Guiot, P.; Bachy, A. 1984: 5 cases of neonatal duodenal obstruction. Acta Chirurgica Belgica 84(5): 273-275
Omura, I.; Ishikawa, K.; Ishibe, T.; Nishiuchi, M.; Ichihara, K. 1970: 5 cases of obstruction of the middle cerebral artery (including a case of obstruction developing during oral administration of luteal follicular. Iryo 24(3): 197-203
Bereczki, Z.; Bárkányi, T. 1973: 5 cases of oral formalin poisoning. Orvosi Hetilap 114(36): 2174-2176
Belkahia, A.; Dimov, V.; Gassab, A.; Ben Jelloul, N.; Kedous, F. 1983: 5 cases of ossifying fibroma of the face. Journal Francais d'Oto-Rhino-Laryngologie; Audiophonologie Chirurgie Maxillo-Faciale 32(6): 352-356
Van Buggenhout, N. 1969: 5 cases of ovarian pregnancy. Bulletin de la Societe Royale Belge de Gynecologie et d'Obstetrique 39(3): 173-180
Jaworski, Z. 1984: 5 cases of partial or complete dislocation of the teeth, conservatively treated. Czasopismo Stomatologiczne 37(6): 417-423
Fukatsu, H.; Yoshida, K. 1967: 5 cases of penile cancer and lymphography. Iryo 21(10): 1141-1152
Bouche, J.; Frèche, C.; Hannequin, M. 1967: 5 cases of primary intrapetrous cholesteatoma. Annales d'Oto-Laryngologie et de Chirurgie Cervico Faciale: Bulletin de la Societe d'Oto-Laryngologie des Hopitaux de Paris 84(9): 663-665
Egawa, J.; Watari, T.; Takenaka, E.; Asakura, H. 1970: 5 cases of radiation induced myelitis. Rinsho Hoshasen. Clinical Radiography 15(10): 758-763
Nakanishi, F.; Fujimori, H.; Yokoyama, T.; Watanabe, T.; Ohata, T. 1969: 5 cases of relatively rare esophageal tumors. Rinsho Hoshasen. Clinical Radiography 14(1): 78-87
Sawaki, M.; Mikasa, K.; Tsujimura, M.; Takezawa, Y.; Ryujin, Y.; Katada, H.; Mikami, R.; Harigane, O.; Masutani, T.; Ishii, Y. 1984: 5 cases of respiratory tract infections due to Haemophilus parainfluenzae confirmed by transtracheal aspiration. Nihon Kyobu Shikkan Gakkai Zasshi 22(5): 407-412
Anzai, T.; Hasegawa, S.; Inamura, N.; Ida, J.; Matsumoto, H. 1974: 5 cases of ruptured aneurysm of the sinus valsalva and 2 cases of ventricular septal defect with the prolapsed aortic valve without insufficiency. Nihon Kyobu Geka Gakkai 22(9): 945-950
Iwamoto, H.; Nakahara, K.; Kimura, K.; Monden, Y.; Maeda, M. 1970: 5 cases of so-called "gangrenous sequestration" of the remaining pulmonary lobe following lobectomy. Kyobu Geka. Japanese Journal of Thoracic Surgery 23(10): 753-759
Saranović, R. 1971: 5 cases of splenic rupture in school children during gymnastics. Srpski Arhiv Za Celokupno Lekarstvo 99(3): 195-198
Chen, Z.A. 1984: 5 cases of sporadic encephalitis treated with Nantong snake-root tablets. Zhong Xi Yi Jie he Za Zhi 4(8): 492-493
Moulin, F. 1967: 5 cases of stenosing tuberculosis of the small intestine. Bulletin et Memoires de la Societe des Chirurgiens de Paris 57(2): 102-111
Deminatti, M.; May, J.P.; Gasnault, J.P.; Delmas-Marsalet, Y.; Kine, A.; Jacqueloot, N.; Savary, J.B. 1971: 5 cases of structural anomalies of the X chromosome and a case of 45,X,2(p+q-). Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 16(7): 957-968
Koposova, T.P.; Fedoseev, A.N. 1969: 5 cases of successful defibrillation at home in acute coronary insufficiency. Vrachebnoe Delo 9: 14-18
Noirfalise, A. 1971: 5 cases of suspected hexapropymate poisoning. European Journal of Toxicology 4(1): 50-52
Paoli, F.; Brandigi, L. 1968: 5 cases of talc aspiration. Rivista di Clinica Pediatrica 81(6): 1129
Sleewaegen, N.; Douniau, R.; Lechien, P.; Fosseur, G. 1971: 5 cases of temporomandibular joint ankylosis in children. Acta Stomatologica Belgica 68(1): 95-108
Jarema, M.; Osuch, Z.; Stańkowska-Chomicz, A. 1981: 5 cases of the cough-syncope syndrome. Neurologia i Neurochirurgia Polska 15(5-6): 537-539
Toty, L.; Hertzog, P.; Diane, C.; Aboudi, A. 1967: 5 cases of tracheo-esophageal fistula after tracheotomy. Annales de Chirurgie Thoracique et Cardio-Vasculaire 6(4): 1155-1158
De Grouchy, J.; Roubin, M. 1965: 5 cases of translocations in a sample of 57 trisomics 21. Annales de Genetique 8(1): 65-66
Motegi, H.; Ono, S.; Kuzu, Y.; Saotome, K.; Yoneyama, K. 1970: 5 cases of traumatic pneumocephalus. No to Shinkei 22(9): 1079-1086
Shimizu, T.; Sawashi, Y.; Mimura, N.; Nagase, M. 1968: 5 cases of uremic pericarditis, complicated by cardiac tamponade during dialysis therapy. Nihon Rinsho. Japanese Journal of Clinical Medicine 26(2): 443-452
Cukier, J.; Benhamou, G.; Laurent, M.; Bouker, T. 1968: 5 cases of urogenital sinus sarcoma in small boys. 2 prolonged survivals after anterior pelvectomy, cellulectomy of the pelvis and chemotherapy. Journal d'Urologie et de Nephrologie 74(10): 813-829
Maestrelli, P.; Marcer, G.; Clonfero, E. 1981: 5 cases of "fluoride asthma". La Medicina del Lavoro 72(4): 306-312
Hotta, T.; Hirabayashi, N.; Kobayashi, T.; Nakamura, S.; Suzuki, Y. 1980: 5 cases showing hemoglobinuria and aplastic crisis following administration of diphenylhydantoin after craniotomy. Japanese Journal of Clinical Hematology 21(4): 536-543
Iwasawa, T.; Namura, S.; Noma, S.; Shishikura, K.; Hanawa, K. 1965: 5 cases treated by multibanded appliance (with reference to non-extraction cases). Nihon Kyosei Shika Gakkai Zasshi 24(1): 42-60
Clauzet, J.M. 1967: 5 cases treated by the method of orthodontics and thoracic orthopedics. L' Orthodontie Francaise 38: 542-544
Krajewska-Martel, A. 1966: 5 cases with initial symptoms of hemorrhagic diathesis in the oral cavity. Czasopismo Stomatologiczne 19(9): 961-964
Heitink, J. 1980: The Intermediate Community Nursing Education as continuation education after the Intermediate Professional Nursing Education (?). Tijdschrift Voor Ziekenverpleging 33(8): 366-367
Roland, V.A. 1968: Paraclinical tests in the diagnosis of T.B.C. meningitis(studies of a series of 98 cases). Revista de la Facultad de Ciencias Medicas de Cordoba 26(3): 319-329
DuShane, J.W.; Weidman, W.H. 1965: 5 congenital cardiac defects. A study of the profile and natural history. Foreword. Circulation 32(6 Suppl): Iii1-Iii3
Anonymous 1966: 5 days of work as a rural instruction team. Taehan Kanho. Korean Nurse 5(1): 95-97
Starek, P.J. 1971: 5 days with a heart transplant team. Medical Times 99(1): 162-164 Passim
Haliţa, M. 1980: 5 decades after the affirmation of Romanian medicine. Revista de Medicina Interna Neurologe Psihiatrie Neurochirurgie Dermato-Venerologie. Medicina Interna 32(2): 189-192
Miskolczy, D.; Baló, J. 1968: 5 decades in the service of science 1917-1967 (Josef Baló). Acta Morphologica Academiae Scientiarum Hungaricae 16(1): 1-5
Shannon, M.L. 1984: 5 famous fallacies about pressure sores. Nursing 14(10): 34-41
Cluzan, R.; Arnavon, P.; Le Blaye, O.; Lehn, E.; Lefesvre, A.; Levillain, R. 1971: 5 fluorouracil in local administration in cancerology. Therapie 26(6): 1211-1217
Barraquer-Bordas, L.; Grau-Veciana, J.M.; Peres-Serra, J.; Balius-Juli, R.; Vandrell-Torné, E. 1966: 5 further cases of acute central cervical medullary syndrome caused by hyperextension. Acta Neurologica et Psychiatrica Belgica 66(2): 99-105
Henrion, R.; Barbizet, J.; Singier, J.R. 1965: 5 further cases of neurologic accidents complicating abortion attempts. Normal development of pregnancies and delivery of living infants. Revue Francaise de Gynecologie et d'Obstetrique 60(11): 649-664
Rometti, A.; Boschi, J. 1972: 5 further cases of primary tumors of the upper urinary tract. Journal d'Urologie et de Nephrologie 78(1): 106-109
Beetschen, J.C. 1967: 5 generations of polyploid individuals in the salamander, Pleurodeles watlii Michah. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 161(4): 930-936
Mochmann, H.; Hergt, R.; Hager, G.; Ernst, K. 1968: 5 individual cases of leptospirosis pomona in the German Democratic Republic. Das Deutsche Gesundheitswesen 23(29): 1356-1362
Behrendt, U. 1967: 5 interesting days. Tidsskrift for Sygeplejersker 67(1): 18-20
Anonymous 1984: 5 items of information important to post-mastectomy patients. Kangogaku Zasshi 48(7): 786-790
Mitchell, M. 1973: 5 major fears of pre-op patients. Rn 36(8): Or13
Sille, F.T. 1970: 5 minutes for a life. Revue de l'Infirmiere et de l'Assistante Sociale 20(8): 792-794
Takahashi, Y. 1968: 5 months as an instructor at the Teachers' Training Institute for the high school nursing course. Japanese Journal of Nursing 20(3): 58-66
Cuartero, C.M.; Ponce, C.; Recio, R. 1967: 5 new cases of Chagas' disease in Zacatecas and Jalisco in the Republic of Mexico. Revista de Investigacion en Salud Publica 27(1): 28-36
Nguyen, H.; Briere, J.; Clavier, J.; Raut, Y.; Leroy, J.P.; Verlingue, R. 1983: 5 new cases of solitary fibrous mesothelioma of the visceral pleura. Le Poumon et le Coeur 39(4): 167-174
Le Minor, L.; Le Minor, S.; Le Couëffic, E.; Huet, M.; Courtois, D.; Albert, J.P.; Ricosse, J.H.; Patinho, M.D.; Le Noc, P. 1972: 5 new serotypes of Salmonella of African origin. Bulletin de la Societe de Pathologie Exotique et de Ses Filiales 65(1): 31-35
Le Bigot, F. 1971: 5 paraphrenic patients in Cameron. Annales Medico-Psychologiques 1(3): 410-415
Van den Berkmortel, F.W.; Wollersheim, H.; Heijstraten, F.M.; Thien, T. 1995: 5 patients with Takayasu's disease in the Netherlands. Nederlands Tijdschrift Voor Geneeskunde 139(22): 1127-1132
Bouma, J. 1967: 5 patients with convulsions following eclampsia or pre-eclampsia. Nederlands Tijdschrift Voor Geneeskunde 111(11): 517-522
Pumarino, H.; Michelsen, H. 1983: 5 perspectives for the study of endocrine changes. An integrated overview. Revista Medica de Chile 111(2): 175-184
Ochiai, K. 1968: 5 points in teaching of medical practice. From the lecture on human relations for graduate nursing studies. Japanese Journal of Nurses' Education 9(6): 52-54
Maeda, M. 1971: 5 points to prevent accidents. Japanese Journal of Nursing 23(10): 66-74
Winter, E.; Dolkeit, K.; Krautmann, K. 1973: 5 primary intestinal cancers. Zentralblatt für Chirurgie 98(11): 403-405
Tatoń, J.; Czech, A. 1982: 5 principles of rational management of diabetes in pregnancy. Polski Tygodnik Lekarski 37(51-52): 1577-1582
Jerie, J. 1970: 5 prominent obstetricians from the Klatovy region in their native country and abroad. Casopis Lekaru Ceskych 109(38): 902-904
Chahla, Y. 1983: 5 rare tumors of the testicle. Journal d'Urologie 89(9): 683-690
Henriksen, K.H. 1980: 5 reasons to select district colleges. Sykepleien 67(16): 33-34
Mirzabekov, A.D.; Griffin, B.E. 1972: 5 s RNA conformation. Studies of its partial T 1 ribonuclease digestion by gel electrophoresis and two-dimensional thin-layer chromatography. Journal of Molecular Biology 72(3): 633-643
Jordan, B.R.; Monier, R. 1971: 5 s RNA molecules formed by reassociation of separated fragments. Journal of Molecular Biology 59(1): 219-222
Naneix, G. 1971: 5 severe eye injuries. Bulletin des Societes d'Ophtalmologie de France 71(7): 830-834
Litsky, B.Y. 1966: 5 steps to remember before you test products. Hospital Management 101(2): 26-32
Drobni, S. 1967: 5 year experiences with a one-stage proctocolectomy with anal ileostomy. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 38(2): 66-69
Sano, K. 1969: 5 year postoperative follow-up results of head injuries, with special reference to intracranial hematoma and depression fractures. Nihon Ishikai Zasshi. Journal of the Japan Medical Association 62(5): 431-434
Kato, S.; Nemoto, S.; Suzuki, G.; Omori, Y.; Kezuka, S. 1969: 5 year statistical observation on ectopic pregnancy in our clinic. Sanfujinka no Jissai. Practice of Gynecology and Obstetrics 18(7): 666-670
Lommatzsch, P.; Vollmar, R.; Lommatzsch, K. 1969: 5 year survival of malignant eyelid neoplasms following radiotherapy. Klinische Monatsblatter für Augenheilkunde 154(4): 486-496
Yokoo, M. 1971: Dilemma of the public health nurse and problems in public health nursing. Japanese Journal for Public Health Nurse 27(3): 113-115
Dortmann, C.; Droh, R.; Frey, R. 1969: 5 years experience with a rescue team. Cahiers d'Anesthesiologie 17(8): 939-943
von Bose, M.J.; Kentsch, M. 1995: 5 years experience with resuscitation courses. Zeitschrift für Arztliche Fortbildung 89(4): 367-369
Kristen, H. 1973: 5 years experience with the immediate and early prosthetics after amputation of lower extremities. Zeitschrift für Orthopadie und ihre Grenzgebiete 111(2): 184-192
Drukker, W.; Haagsma-Schouten, W.A.; Alberts, C.; Blomjous, A. 1974: 5 years home dialysis. Nederlands Tijdschrift Voor Geneeskunde 118(33): 1259-1265
Wu, L.L. 1968: 5 years in a psychiatric sanatarium. Hu Li Za Zhi Journal of Nursing 15(3): 33-35
Björck, S. 1972: 5 years management of patients under anesthesia. Tidskrift for Sveriges Sjukskoterskor 39(16): 4-5
Saunders, C. 1968: Care of the dying. Deutsche Schwesternzeitung 21(11): 565-567
Skalova, R.; Tambić, T.; Ferluga, C.; Batusić, M. 1973: Could hospital infections be predicted?. Infection 1(1): 32-34
Kotvald, T. 1968: 5 years of activity and new tasks of the economic section of the Research Institute of Public Health Organization. Ceskoslovenske Zdravotnictvi 16(7): 364-367
Smiech-Slomkowska, G.; Pasek-Kossakowska, K. 1973: 5 years of activity of District Orthodontic Outpatient Clinic in Lódź--Widzew (1966-1971). Czasopismo Stomatologiczne 26(2): 197-199
Spada, A.; Gennaro, T.; Ambrosiani, S. 1968: 5 years of antirheumatic therapy at the Divisione Pediatrica dell'Ospedale Civile of Cuneo. Clinical, therapeutic and preventive aspects. Minerva Medica 59(103): 5755-5762
Tzonchev, V.T. 1972: 5 years of compulsory declaration of acute articular rheumatism in the Bulgarian People's Republic. Revista Espanola de Reumatismo Y Enfermedades Osteoarticulares 15(3): 165-174
Preibisch-Effenberger, R. 1970: 5 years of endolaryngeal ultrasonic therapy in juvenile laryngeal papilloma. Zeitschrift für Arztliche Fortbildung 64(22): 1150-1154
Consiglio, L.; Taddei, P.; Rosmini, M.; Luccioli, G.M. 1980: 5 years of experience in arterial vascular surgery (January 1972-December 1977). Minerva Chirurgica 35(20): 1559-1564
Varela, G. 1967: 5 years of experience in keeping Pediculus humanus colonies in the laboratory. Revista de Investigacion en Salud Publica 27(4): 317-320
Savel'ev, V.S.; Savchuk, B.D.; Kostenko, I.G. 1967: 5 years of experience in the surgical treatment of transverse heart block. Grudnaia Khirurgiia 9(2): 3-9
Bucher, R.; Wegmann, T. 1965: 5 years of experience with Reverin. Schweizerische Medizinische Wochenschrift 95(47): 1621-1628
Rothermich, N.O. 1967: 5 years of experience with indomethacin. La Clinica Terapeutica 41(5): 411-429
Meyer, W.L. 1971: 5 years of experience with the patient in the recumbent position. Ddz. das Deutsche Zahnarzteblatt 25(11): 419-421
Klein, W. 1970: 5 years of experience with the transvenous-intracardial pacemaker. Wiener Zeitschrift für Innere Medizin und ihre Grenzgebiete 51(4): 167-178
Koganezawa, S.; Yoshii, I.; Sato, K. 1970: 5 years of follow-up results of ligation-resection of hemorrhoids. Nihon Daicho Komonbyo Gakkai Zasshi 23(1): 52
Talssh, M.; Chumakov, M.P.; Zavodova, T.I. 1969: 5 years of observing monkeys infected with simian virus 40 during the 1st days of life. Voprosy Virusologii 14(3): 301-305
Bruggmoser, G.; Kuphal, K. 1980: 5 years of operation experience with a 4 MeV linear accelerator in radiotherapy. Strahlentherapie 156(3): 158-161
Hájek, V. 1971: 5 years of personal dosimetry at a diagnostic x-ray department. Ceskoslovenska Radiologie 25(4): 153-158
Jutras, R.; Bolduc, J.M. 1973: 5 years of prevention of perinatal mortality (1968-1972). La Vie Medicale au Canada Francais 2(8): 775-782
Duska, F.; Novák, J.; Vizda, J.; Kafka, P.; Kubícek, J.; Veverková, O. 1982: 5 years of pyrophosphate scanning of the heart. A set of results from clinical practice. Casopis Lekaru Ceskych 121(33): 1043-1046
Ott, A. 1971: 5 years of radiotherapy of bronchial carcinoma with high-energy electrons. Strahlentherapie 141(2): 141-144
Menner, K. 1967: 5 years of recurrence prevention of rheumatic fever using benzathine penicillin. Die Medizinische Welt 45: 2723-2725
Anonymous 1970: 5 years of studies on treponematosis and venereal diseases. Prensa Medica Argentina 57(12): 585-591
Thalhammer, O.; Scheibenreiter, S.; Schön, R.; Knoll, E.; Schmierer, G. 1972: 5 years of the Austrian program for the early detection of inborn errors of metabolism. Activity report. Wiener Klinische Wochenschrift 84: Suppl. 2: 3-12
Anders, K.E. 1983: 5 years of the new family law. Have we come closer to equal rights?. Fortschritte der Medizin 101(29): 1311-1312
Clavé, M. 1984: 5 years old and operation for a urinary malformation. Revue de l'Infirmiere 34(19): 26-32
Tamussino, K.; Zivkovic, F.; Pieber, D.; Ralph, G. 1995: 5 years results of incontinence operations. Gynakologisch-Geburtshilfliche Rundschau 35(3): 175-176
Rygård, J.; Hansen, H.S. 1966: 5 years symptom-free survival rate of 414 consecutive cases of laryngeal cancer referred to the radium centre Copenhagen. Acta Oto-Laryngologica Suppl 224: 482+
Abaza, A.; Paradis, R. 1968: 5 years treatment of arterial hypertension with a monoamine oxidase inhibiter (Marsilid). Annales de Cardiologie et d'Angeiologie 17(1): 63-76
Ladnyĭ, I.D.; Gromyko, A.I. 1983: 5 years without smallpox: problems and outlooks. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 9: 7-11
Wirth-Flynn, M. 1984: 5 years' clinical follow-up of 2 composites in dental enamel defects. Zahn- Mund- und Kieferheilkunde Mit Zentralblatt 72(3): 240-243
Kofer, J. 1985: 5 years' cooperation between pediatricians and district departments of medical genetics in the North Bohemian Region. Ceskoslovenska Pediatrie 40(11): 681-682
Linnik, L.A. 1969: 5 years' experience in the application of laser coagulation in the clinical treatment of retinal detachment. Oftalmologicheskii Zhurnal 24(3): 171-176
Humphrey, L.J.; Boehm, O.R.; Boehm, B.J.; Jewell, W.R. 1973: 5 years' experience in the immunotherapy of human cancer. Zentralblatt für Chirurgie 98(35): 1241-1246
Terlikbaev, A.A.; Shefer, L.B.; Valieva, R.G.; Kalacheva, D.N.; Gromysheva, N.F. 1983: 5 years' experience operating an automated system of accounting for the patient contingents of tuberculosis institutions in the Kazakh SSR. Problemy Tuberkuleza 1983(1): 9-13
Boen, S.T.; Scribner, B.H. 1966: 5 years' experience with chronic hemodialysis. Nederlands Tijdschrift Voor Geneeskunde 110(5): 229-238
Ulrich, J. 1985: 5 years' experience with ischemic disease of the lower extremities at 2 internal medicine departments in the Most District. Vnitrni Lekarstvi 31(12): 1152-1156
Badó, Z.; Papp, L.G.; Tari, G.; Vekerdy, M. 1983: 5 years' experience with knee joint endoprosthesis. Zentralblatt für Chirurgie 108(7): 418-424
Pifano, E.; Acevedo, F.; Carbonell, E.; Chávez, R.; Bousquet, J. 1981: 5 years' experience with parietal cell vagotomy. G.E.N 35(1-2): 1-6
Lopez-Ibor Aliño, J.M.; Tabares Pujante, J. 1973: 5 years' experience with prolonged-action neuroleptics. Actas Luso-Espanolas de Neurologia Psiquiatria y Ciencias Afines 1(5): 721-731
Crespo, L.; Bove, D.; Farrell, G.; Soltanik 1983: 5 years' experience with revascularization of the corpus cavernosum by a new microsurgical technic in the treatment of vascular sexual impotence. Journal d'Urologie 89(8): 587-593
Steffen, F.W. 1966: 5 years' experience with silver nitrate and oestrasid-ovula in the treatment of cervical ectopia and erosion. Zentralblatt für Gynakologie 88(16): 489-496
Reggiani, M.; Cremonesi, G. 1983: 5 years' experience with spectinomycin in treating gonorrhea. Minerva Medica 74(14-15): 815-817
Andersen, O.P.; Larsen, F.; Boss, H.C. 1980: 5 years' experience with the copper-T in general practice. Ugeskrift for Laeger 142(47): 3127-3128
Parouty, J. 1970: 5 years' experience with the use of exposure automatons in routine radiodiagnosis. Journal de Radiologie d'Electrologie et de Medecine Nucleaire 51(12): 773-777
Voigt, J.; Lennert, K.; Hedderich, J. 1984: 5 years' general drug prevention of thromboembolism in general surgery. Comparison of personal experiences with results from the literature. Fortschritte der Medizin 102(20): 562-564
Horner-Vallet, D.; Cappelaere, P.; Delobelle, A.; Depadt, G.; Madelain, M.; Demaille, A. 1984: 5 years' results of a CMF protocol (methotrexate, cyclophosphamide, fluorouracil) of adjuvant chemotherapy in breast cancers. Larc Medical 4(9): 532-540
Popiela, T.; Herman, R.M.; Legutko, J. 1983: 5 years' results of prospective clinical studies on the treatment of duodenal ulcer by vagotomy or denervation of the gastric corpus and fundus. Polski Tygodnik Lekarski 38(47): 1453-1456
Hamada, T. 1966: 5 years' survey of patients with vitiligo at the Osaka City University Hospital during 1960-1964. Hifuka Kiyo. Acta Dermatologica 61(2): 92-99
Hammer, O. 1974: 5 yearss of the Bad Mayheim nicotine withdrawal therapy and non-smoker's training. Münchener Medizinische Wochenschrift 116(11): 565-568
Simpson, N.B.; McGregor, K.A. 1982: 5% Aluminium chloride hexahydrate and sebum excretion rate. Acta Dermato-Venereologica 62(5): 429-431
Szmigielski, S.; Jeljaszewicz, J.; Wilczynski, J. 1966: 5' -nucleotidase activity in rabbit leukocytes during experimental infections. Pathologia et Microbiologia 29(2): 186-192
Day, L.E.; Hirst, A.J.; Lai, E.C.; Mace, M.; Woo, S.L. 1981: 5' Domain and nucleotide sequence of an adult chicken chromosomal beta-globin gene. Biochemistry 20(8): 2091-2098
Marcu, K.B.; Banerji, J.; Penncavage, N.A.; Lang, R.; Arnheim, N. 1980: 5' flanking region of immunoglobulin heavy chain constant region genes displays length heterogeneity in germlines of inbred mouse strains. Cell 22(1 Part 1): 187-196
Platzer, C.; Volk, H.D.; Platzer, M. 1994: 5' noncoding sequence of human IL-10 gene obtained by oligo-cassette PCR walking. Dna Sequence: the Journal of Dna Sequencing and Mapping 4(6): 399-401
Henderson, B.; Johnstone, J.J.; Chayen, J. 1980: 5' nucleotidase activity in the human synovial lining in rheumatoid arthritis. Annals of the Rheumatic Diseases 39(3): 248-252
Moretti, G.; Staeffen, J.; Ballan, P.; Ferrer, J.; Dubecq, J.P.; Roques, J.C.; Beylot, J.; Broustet, A. 1970: 5' nucleotidase: a specific hepato-biliary alkaline phosphatase. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 46(46): 3004-3012
Lovinger, G.G.; Schochetman, G. 1980: 5' terminal nucleotide sequences of type C retroviruses: features common to noncoding sequences of eucaryotic messenger RNAs. Cell 20(2): 441-449
Geremia, R.; Boitani, C.; Conti, M.; Mocini, D.; Monesi, V. 1981: 5',3' Cyclic adenosine monophosphate dependent protein phosphorylation in differentiating male mouse germ cells. Cell Biology International Reports 5(12): 1071
Mateo, J.; Castro, E.; Zwiller, J.; Aunis, D.; Miras-Portugal, M.T. 1995: 5'-(N-ethylcarboxamido)adenosine inhibits Ca2+ influx and activates a protein phosphatase in bovine adrenal chromaffin cells. Journal of Neurochemistry 64(1): 77-84
Chaconas, G.; van de Sande, J.H. 1980: 5'-32P labeling of RNA and DNA restriction fragments. Methods in Enzymology 65(1): 75-85
Todhunter, J.A.; Purich, D.L. 1974: 5'-Adenylylation and 5'-uridylation of N-acetyl tyrosine ethyl ester: a general synthesis of 5'-nucleotidylated tyrosyl residues. Biochemical and Biophysical Research Communications 59(1): 82-85
Chen, M.S.; Shiau, G.T.; Prusoff, W.H. 1980: 5'-Amino-5'-deoxythymidine: synthesis, specific phosphorylation by herpesvirus thymidine kinase, and stability to pH of the enzymically formed diphosphate derivative. Antimicrobial Agents and ChemoTherapy 18(3): 433-436
Schattka, K.; Jastorff, B. 1972: 5'-Amino-5'-desoxyguanosine and its 5'-N-substituted derivatives. Chemische Berichte 105(12): 3824-3832
Simeone, A.; Boncinelli, E. 1984: 5'-Cleavage site of D. melanogaster 18 S rRNA. Febs Letters 167(2): 249-253
Langen, P.; Kowollik, G. 1968: 5'-Deoxy-5'-fluoro-thymidine, a biochemical analogue of thymidine-5'-monophosphate selectively inhibiting DNA synthesis. European Journal of Biochemistry 6(3): 344-351
Christa, L.; Thuillier, L.; Perignon, J.L. 1983: 5'-Deoxy-5'-methylthioadenosine inhibition of rat T lymphocyte phosphodiesterase: correlation with inhibition of Con a induced proliferation. Biochemical and Biophysical Research Communications 113(2): 425-432
Hara, Y. 1984: 5'-Deoxy-5-fluorouridine enzymatic activation from the masked compound to 5-fluorouracil in human malignant tissues. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(10): 2133-2143
Armstrong, R.D.; Cadman, E. 1983: 5'-Deoxy-5-fluorouridine selective toxicity for human tumor cells compared to human bone marrow. Cancer Research 43(6): 2525-2528
Plagemann, P.G.; Wohlhueter, R.M. 1983: 5'-Deoxyadenosine metabolism in various mammalian cell lines. Biochemical Pharmacology 32(8): 1433-1440
O'Brien, J.M.; Thanassi, J.W.; Cidlowski, J.A. 1980: 5'-Deoxypyridoxal inhibition of glucocorticoid receptor binding in Hela S3 cells and rat thymocytes. Biochemical and Biophysical Research Communications 92(1): 155-162
Slack, J.M.; Loening, U.E. 1974: 5'-Ends of ribosomal and ribosomal precursor RNAs form Xenopus laevis. European Journal of Biochemistry 43(1): 59-67
Londos, C.; Salomon, Y.; Lin, M.C.; Harwood, J.P.; Schramm, M.; Wolff, J.; Rodbell, M. 1974: 5'-Guanylylimidodiphosphate, a potent activator of adenylate cyclase systems in eukaryotic cells. Proceedings of the National Academy of Sciences of the United States of America 71(8): 3087-3090
Sertic-Pritsos, K.; Vinocour, M.; Winicov, I. 1984: 5'-Hydroxyl RNA kinase from mouse L cells. European Journal of Biochemistry 144(1): 47-55
Boseley, P.G.; Moss, T.; Birnstiel, M.L. 1980: 5'-Labeling and poly(dA) tailing. Methods in Enzymology 65(1): 478-494
Miller, D.W.; Elgin, S.C. 1982: 5'-Mercuri-uridine triphosphate as a substrate for transcription. Analytical Biochemistry 123(1): 94-100
Agarwal, K.C.; Parks, R.E. 1980: 5'-Methylthioadenosine and 2',5'-dideoxyadenosine blockade of the inhibitory effects of adenosine on ADP-induced platelet aggregation by different mechanisms. Biochemical Pharmacology 29(18): 2529-2532
Kaneko, K.; Fujimori, S.; Kamatani, N.; Akaoka, I. 1984: 5'-Methylthioadenosine in urine from normal subjects and cancer patients. Biochimica et Biophysica Acta 802(2): 169-174
Kamatani, N.; Kubota, M.; Willis, E.H.; Frincke, L.A.; Carson, D.A. 1984: 5'-Methylthioadenosine is the major source of adenine in human cells. Advances in Experimental Medicine and Biology 165 Pt B: 83-88
Backlund, P.S.; Smith, R.A. 1982: 5'-Methylthioadenosine metabolism and methionine synthesis in mammalian cells grown in culture. Biochemical and Biophysical Research Communications 108(2): 687-695
Guranowski, A.B.; Chiang, P.K.; Cantoni, G.L. 1981: 5'-Methylthioadenosine nucleosidase. Purification and characterization of the enzyme from Lupinus luteus seeds. European Journal of Biochemistry 114(2): 293-299
Kamatani, N.; Kubota, M.; Willis, E.H.; Carson, D.A. 1984: 5'-Methylthioadenosine phosphorylase deficiency in malignant cells: recessive expression of the defective phenotype in intraspecies (mouse X mouse) hybrids. Advances in Experimental Medicine and Biology 165 Pt B: 279-283
Savarese, T.M.; Crabtree, G.W.; Parks, R.E. 1981: 5'-Methylthioadenosine phosphorylase-L. Substrate activity of 5'-deoxyadenosine with the enzyme from Sarcoma 180 cells. Biochemical Pharmacology 30(3): 189-199
Cusack, N.J.; Hourani, S.M. 1981: 5'-N-ethylcarboxamidoadenosine: a potent inhibitor of human platelet aggregation. British Journal of Pharmacology 72(3): 443-447
Lichtenthaler, F.W.; Müller, H.J. 1973: 5'-Nitrates of pyrimidine nucleosides: nitric acid analogs of nucleotides. Angewandte Chemie 12(9): 752-753
Berman, J.J.; Tong, C.; Williams, G.M. 1980: 5'-Nucleotidase activities in cultured rat liver epithelial and fibroblast cells. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 28(2): 174-180
Fritzson, P. 1968: 5'-Nucleotidase activities in the soluble fraction of rat liver. Biochimica et Biophysica Acta 151(3): 716-718
Dooley, J.F.; Racich, L. 1982: 5'-Nucleotidase activity enhanced by manganese and magnesium ions with inosine monophosphate substrate. Clinical Chemistry 28(4 Part 1): 726-727
Amano, S.; Kreutzberg, G.W.; Reddington, M. 1983: 5'-Nucleotidase activity in human astrocytomas. Acta Neuropathologica 59(2): 145-149
Szmigielski, S. 1965: 5'-Nucleotidase activity in human blood granulocytes during acute infections. Folia Haematologica 84(4): 402-405
Agostini, C.; Secchi, M.; Venturelli, D. 1980: 5'-Nucleotidase activity in liver homogenates of rats treated with CCl4, colchicine, cycloheximide, emetine, ethanol, ethionine and 5-fluorotryptophan. Experientia 36(9): 1067-1068
Uusitalo, R.J. 1981: 5'-Nucleotidase activity in lymphocytes. Histochemical Journal 13(4): 525-534
Gerber, P.S.; Herrod, H.G. 1983: 5'-Nucleotidase activity in subjects with abnormal lymphocyte function. Journal of Clinical Immunology 3(3): 222-227
Kar, N.C.; Pearson, C.M. 1973: 5'-Nucleotidase activity of normal and dystrophic human muscle. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 143(4): 1125-1126
Suran, A.A. 1974: 5'-Nucleotidase and acid phosphatase of spinal cord. Quantitative histochemistry in cat and mouse spinal cords and in mouse brain. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 22(8): 812-818
Suran, A.A. 1974: 5'-Nucleotidase and an acid phosphatase of spinal cord. Comparative histochemistry and specificity of the enzymes in mouse and cat spinal cords. Cytologic localization in mouse substantia gelatinosa. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 22(8): 802-811
Sergeev, P.V.; Denisov, I.P.; Suleĭmanov, S.S.; Shutko, G.V. 1982: 5'-Nucleotidase as an "internal probe" in studying steroid hormone interaction with the plasma membranes of target cells. Farmakologiia i Toksikologiia 45(4): 101-105
Meflah, K.; Harb, J.; Duflos, Y.; Bernard, S. 1984: 5'-Nucleotidase from bovine caudate nucleus synaptic plasma membranes: specificity for substrates and cations; study of the carbohydrate moiety by glycosidases. Journal of Neurochemistry 42(4): 1107-1115
Naito, Y.; Lowenstein, J.M. 1981: 5'-Nucleotidase from rat heart. Biochemistry 20(18): 5188-5194
El-Mohandes, E.; Hayhoe, F.G. 1983: 5'-Nucleotidase in lymphocytes from various clinical disorders. Leukemia Research 7(1): 57-66
Whetton, A.D.; Houslay, M.D. 1983: 5'-Nucleotidase is activated upon cholesterol-depletion of liver plasma membranes. Febs Letters 157(1): 70-74
Hardonk, M.J.; Jonkers, A. 1972: 5'-Nucleotidase. VI. Sex differences in the localization of rat liver 5'-nucleotidase activity. HISTOCHEMIE. Histochemistry. Histochimie 32(4): 363-368
Ito, R.; Tsushima, K. 1972: 5'-Nucleotidase: enzymological and biological studies. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 17(12): 906-914
Magni, G.; Fioretti, E.; Natalini, P.; Felicioli, R.A. 1973: 5'-Nucleotidase: some properties of guinea pig skeletal muscle and bovine milk serum enzyme. Acta Vitaminologica et Enzymologica 27(1): 129-134
Tsou, K.C.; Morris, H.P.; Lo, K.W.; Muscato, J.J. 1974: 5'-Nucleotide phosphodiesterase activity in rat hepatoma. Cancer Research 34(6): 1295-1298
Tsou, K.C.; McCoy, M.G.; Enterline, H.T.; Herberman, R.; Wahner, H. 1973: 5'-Nucleotide phosphodiesterase isoenzyme and hepatic cancer in NCI-Mayo Clinic panel sera. Journal of the National Cancer Institute 51(6): 2005-2006
Tsou, K.C.; Ledis, S.; McCoy, M.G. 1973: 5'-Nucleotide phosphodiesterase isoenzyme pattern in the serum of human hepatoma. Cancer Research 33(10): 2215-2217
Tsou, K.C.; Creech, R.H.; Inouye, W.Y.; Lo, K.W. 1984: 5'-Nucleotide phosphodiesterase isozyme-V as a marker for liver metastases in breast cancer patients. Cancer 54(9): 1788-1793
Lei-Injo, L.E.; Tsou, K.C.; Lo, K.W.; Lopez, C.G.; Balasegaram, M.; Ganesan, S. 1980: 5'-Nucleotide phosphodiesterase isozyme-V in health, in cancer, and in viral hepatitis. Cancer 45(4): 795-798
Landt, M.; Everard, R.A.; Butler, L.G. 1980: 5'-Nucleotide phosphodiesterase: features of the substrate binding site as deduced from specificity and kinetics of some novel substrates. Biochemistry 19(1): 138-143
LePage, G.A.; Lin, Y.T.; Orth, R.E.; Gottlieb, J.A. 1972: 5'-Nucleotides as potential formulations for administering nucleoside analogs in man. Cancer Research 32(11): 2441-2444
Rhee, S.G. 1984: 5'-Nucleotidyl-O-tyrosine bond in glutamine synthetase. Methods in Enzymology 107: 183-200
Torrence, P.F.; Imai, J.; Johnston, M.I. 1981: 5'-O-Monophosphoryladenylyl(2' goes to 5')adenylyl(2' goes to 5')adenosine is an antagonist of the action of 5'-O-triphosphoryladenylyl-(2' goes to 5')adenylyl(2' goes to 5')adenosine and double-stranded RNA. Proceedings of the National Academy of Sciences of the United States of America 78(10): 5993-5997
Giziewicz, J.; Kuśmierek, J.T.; Shugar, D. 1972: 5'-O-methyl derivatives of 1- -D-arabinofuranosylcytosine and 1- -D-arabinofuranosyluracil. Journal of Medicinal Chemistry 15(8): 839-840
Tanner, D.; Nobrega, F.G.; Oishi, M. 1972: 5'-Oligonucleotides as the acid-soluble products of the ATP-dependent DNase form Escherichia coli. Journal of Molecular Biology 67(3): 513-516
Tatarskaya, R.I.; Lvova, T.N.; Abrossimova-Amelyanchik; Korenyako, A.I.; Bayev, A.A. 1970: 5'-P-forming exonuclease from Actinomyces sp. of coelicolor group, strain No. 5 (exonuclease a 5). Purification and some properties. European Journal of Biochemistry 15(3): 442-449
Kolakowska-Polubiec, K.; Litwin, J.; Nasilowski, W.; Slomkowski, M.; Zupańska, B. 1970: 5'-Ribonucleotide phosphohydrolase activity in peripheral blood granulocytes of rats after burns. Polish Medical Journal 9(1): 119-121
Sugiura, M. 1972: 5'-Terminal analysis of RNA with polynucleotide kinase. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 1972(Suppl): 244-250
Wallace, J.C.; Wood, W.M.; Edmonds, M. 1981: 5'-Terminal cap structures of oligo(uridylic acid)-containing messenger ribonucleic acid from Hela cells: comparison with other ribonucleic acid subpopulations. Biochemistry 20(19): 5364-5368
Shatkin, A.J.; Darzynkiewicz, E.; Furuichi, Y.; Kroath, H.; Morgan, M.A.; Tahara, S.M.; Yamakawa, M. 1982: 5'-Terminal caps, cap-binding proteins and eukaryotic mRNA function. Biochemical Society Symposium 47: 129-143
Pettersson, R.F. 1981: 5'-Terminal nucleotide sequence of Semliki forest virus 18S defective interfering RNA is heterogeneous and different from the genomic 42S RNA. Proceedings of the National Academy of Sciences of the United States of America 78(1): 115-119
Land, H.; Grez, M.; Hauser, H.; Lindenmaier, W.; Schütz, G. 1981: 5'-Terminal sequences of eucaryotic mRNA can be cloned with high efficiency. Nucleic Acids Research 9(10): 2251-2266
Shimotono, K.; Miura, K. 1974: 5'-Terminal structure of messenger RNA transcribed by RNA polymerase of silkworm cytoplasmic polyhedrosis virus containing double-stranded RNA. Journal of Molecular Biology 86(1): 21-30
Verbert, A.P.; Sergeant, A.; Krsmanovic, V. 1974: 5'-TriphosphaTe termini of RNAs made in vivo and in vitro by Hela and KB cell DNA-dependent RNA polymerases. Biochimie 56(8): 1103-1110
Farquhar, D.; Chen, R.; Khan, S. 1995: 5'-[4-(Pivaloyloxy)-1,3,2-dioxaphosphorinan-2-yl]-2'-deoxy-5-fluorouridine: a membrane-permeating prodrug of 5-fluoro-2'-deoxyuridylic acid (FdUMP). Journal of Medicinal Chemistry 38(3): 488-495
Takata, Y.; Fujioka, M. 1984: 5'-[p-(Fluorosulfonyl)benzoyl]adenosine-mediated inactivation of S-adenosylhomocysteinase. Biochemistry 23(19): 4357-4362
Hemphill, R.M.; Zielke, C.L.; Suelter, C.H. 1971: 5'-adenosine monophosphate aminohydrolase. Evidence for anomalous substrate saturation kinetics at low enzyme concentrations. Journal of Biological Chemistry 246(23): 7237-7240
Shapiro, B.M.; Stadtman, E.R. 1968: 5'-adenylyl-O-tyrosine. the novel phosphodiester residue of adenylylated glutamine synthetase from Escherichia coli. Journal of Biological Chemistry 243(13): 3769-3771
Murayama, A.; Jastorff, B.; Cramer, F.; Hettler, H. 1971: 5'-amido analogs of adenosine 3',5'-cyclic monophosphate. Journal of Organic Chemistry 36(20): 3029-3033
Savarese, T.M.; Dexter, D.L.; Parks, R.E. 1983: 5'-deoxy-5'-methylthioadenosine phosphorylase--II. Role of the enzyme in the metabolism and antineoplastic action of adenine-substituted analogs of 5'-deoxy-5'-methylthioadenosine. Biochemical Pharmacology 32(12): 1907-1916
Rossomando, E.F.; Cordis, G.A.; Markham, G.D. 1983: 5'-deoxy-5'-thioanalogs of adenosine and inosine 5'-monophosphate: studies with 5'-nucleotidase and alkaline phosphatase. Archives of Biochemistry and Biophysics 220(1): 71-78
Hartmann, H.R.; Bollag, W. 1980: 5'-deoxy-5-fluoruridine, a new antineoplastic pyrimidine antimetabolite. Schweizerische Medizinische Wochenschrift 110(27-28): 1078-1080
O'Brien, J.M.; Cidlowski, J.A. 1982: 5'-deoxypyridoxal interaction with dexamethasone receptor: a new probe for structure and function of steroid receptors. Biochemistry 21(22): 5644-5650
Langen, P.; Kowollik, G. 1968: 5'-desoxy-5'-fluorothymidine, a new inhibitor of the DNA synthesis. Acta Biologica et Medica Germanica 20(3): 417-419
Hipskind, R.A.; Clarkson, S.G. 1983: 5'-flanking sequences that inhibit in vitro transcription of a xenopus laevis tRNA gene. Cell 34(3): 881-890
El-Mohandes, E.A.; Hayhoe, F.G. 1983: 5'-nucleotidase activity in myeloma cells. Clinical and Laboratory Haematology 5(3): 265-269
Sun, A.S.; Holland, J.F.; Ohnuma, T.; Slankard-Chahinian, M. 1982: 5'-nucleotidase activity in permanent human lymphoid cell lines. Implication for cell proliferation and aging in vitro. Biochimica et Biophysica Acta 714(3): 530-535
Goranov, K. 1984: 5'-nucleotidase activity in the organs of cattle, sheep and swine. Veterinarno-Meditsinski Nauki 21(10): 37-41
Jafri, A.K.; Asghar, S.S.; Khawaja, D.K. 1970: 5'-nucleotidase activity in the tissues of the freshwater murrel, Ophicephalus punctatus Bloch. Enzymologia 39(4): 205-210
Beliaeva, E.M.; Vinetskiĭ, I.P. 1968: 5'-nucleotidase activity of the tissue of irradiated rats. Biulleten' Eksperimental'noi Biologii i Meditsiny 65(3): 57-59
Dornand, J.; Bonnafous, J.C.; Mani, J.C. 1980: 5'-nucleotidase activity of two populations of mouse thymocytes separated by peanut agglutinin agglutination. Febs Letters 118(2): 225-228
Cammer, W.; Sirota, S.R.; Zimmerman, T.R.; Norton, W.T. 1980: 5'-nucleotidase in rat brain myelin. Journal of Neurochemistry 35(2): 367-373
Cammer, W.; Zimmerman, T.R. 1982: 5'-nucleotidase in sciatic nerves from adult and young rats: recovery in myelin is lower than the recoveries of 2', 3'-cyclic nucleotide-3' -phosphohydrolase and carbonic anhydrase. Neurochemical Research 7(2): 229-234
Itoh, R.; Mitsui, A.; Tsushima, K. 1967: 5'-nucleotidase of chicken liver. Biochimica et Biophysica Acta 146(1): 151-159
Song, C.S.; Kappas, A.; Bodansky, O. 1969: 5'-nucleotidase of plasma membranes of the rat liver: studies on subcellular distribution. Annals of the new York Academy of Sciences 166(2): 565-573
Dornand, J.; Bonnafous, J.C.; Mani, J.C. 1980: 5'-nucleotidase--adenylate cyclase relationships in mouse thymocytes. a re-evaluation of the effects of concanavalin a on cyclic AMP levels. Febs Letters 110(1): 30-34
Hardonk, M.J. 1968: 5'-nucleotidase. I. Distribution of 5'-nucleotidase in tissues of rat and mouse. HISTOCHEMIE. Histochemistry. Histochimie 12(1): 1-17
Hardonk, M.J.; Koudstaal, J. 1968: 5'-nucleotidase. II. the significance of 5'-nucleotidase in the metabolism of nucleotides studied by histochemical and biochemical methods. HISTOCHEMIE. Histochemistry. Histochimie 12(1): 18-28
Hardonk, M.J.; Koudstaal, J. 1968: 5'-nucleotidase. IV. Localization of 5'-nucleotidase and alkaline phosphatase isoenzymes in the kidney of young and adult mice. Histochemie. Histochemistry. Histochimie 15(4): 290-299
Limbird, L.E.; Buhrow, S.A.; Speck, J.L.; Staros, J.V. 1983: 5'-p-Fluorosulfonylbenzoyl guanosine as a probe for the GTP-binding protein in alpha 2-adrenergic receptor-adenylate cyclase systems. Journal of Biological Chemistry 258(17): 10289-10293
Togashi, C.T.; Reisler, E. 1982: 5'-p-Fluorosulfonylbenzoyladenosine. Inactivation of myosin subfragment 1 and a model reaction with cysteine. Journal of Biological Chemistry 257(17): 10112-10118
Cooper, J.B.; Winter, C.G. 1980: 5'-p-fluorosulfonylbenzoyladenosine as an ATP site affinity probe for Na+, K+-ATPase. Journal of Supramolecular Structure 13(2): 165-174
Banerjee, A.K. 1980: 5'-terminal cap structure in eucaryotic messenger ribonucleic acids. Microbiological Reviews 44(2): 175-205
Mizumoto, K. 1983: 5'-terminal cap structure in eukaryotic mRNAs. Seikagaku. Journal of Japanese Biochemical Society 55(10): 1178-1196
Tereba, A. 1981: 5'-terminal deletions are a common feature of endogenous retrovirus loci located on chromosome 1 of White Leghorn chickens. Journal of Virology 40(3): 920-926
Inoue, A.; Nakamura, M.; Nakanishi, S.; Hidaka, S.; Miura, K.; Numa, S. 1981: 5'-terminal nucleotide sequence of the messenger RNA coding for bovine corticotropin/beta-lipotropin precursor. European Journal of Biochemistry 113(3): 531-539
Dornand, J.; Bonnafous, J.C.; Favero, J.; Gartner, A.; Mani, J.C. 1984: 5'Nucleotidase and adenosine deaminase activities in human lymphocytes and lymphoblastoid cell lines. Advances in Experimental Medicine and Biology 165 Pt B: 261-266
Gerber, P.S.; Herrod, H.G. 1983: 5'nucleotidase activity in mitogen-stimulated adult and cord blood lymphocyte cultures. Pediatric Research 17(6): 474-477
Sylwestrowicz, T.A.; Ma, D.D.; Murphy, P.P.; Massaia, M.; Prentice, H.G.; Hoffbrand, A.V.; Greaves, M.F. 1982: 5'nucleotidase, adenosine deaminase and purine nucleoside phosphorylase activities in acute leukaemia. Leukemia Research 6(4): 475-482
Goldberg, D.M. 1973: 5'nucleotidase: recent advances in cell biology, methodology and clinical significance. Digestion 8(1): 87-99
De Clercq, E.; Balzarini, J.; Chang, C.T.; Bigge, C.F.; Kalaritis, P.; Mertes, M.P. 1980: 5(E)-(3-azidostyryl)-2'-deoxyuridine 5'-phosphate is a photoactivated inhibitor of thymidylate synthetase. Biochemical and Biophysical Research Communications 97(3): 1068-1075
Pittillo, R.F.; Hunt, D.E. 1967: 5(or 4)-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4(or 5)-carboxamide (NSC-82196): microbiologic evaluation and assay. Cancer ChemoTherapy Reports 51(4): 213-223
Hunt, D.E.; Pittillo, R.F. 1968: 5(or 4)-(3,3-dimethyl-1-triazeno)imidazole-4(or 5)-carboxamide (NSC-45388): microbiologic assay in mouse tissues. Cancer ChemoTherapy Reports 52(5): 553-556
James, R.H.; Sternglanz, P.D.; Shealy, Y.F. 1969: 5(or 4)-[3,3-Bis(2-chloroethyl)-1-triazeno]imidazole-4(or 5)-carboxamide: a titrimetric determination of its v-triazolinium transformation product and studies of its stability. Journal of Pharmaceutical Sciences 58(10): 1193-1195
Carter, S.K.; Newman, J.W. 1968: 5(or 4)-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4(or 5)-carboxamide (NSC-82196)--clinical brochure. Cancer ChemoTherapy Reports. Part 1(1): 63-80
Bessière, L. 1970: 5,000 cases of plantar warts cured under occlusive dressing. Bulletin de la Societe Francaise de Dermatologie et de Syphiligraphie 77(1): 126-127
Yale, H.L. 1968: 5,11-Dihydrodibenz[b,e][1,4]oxazepine-5-carboxamides. Compounds potentially useful in the treatment of epilepsy and trigeminal neuralgia. Journal of Medicinal Chemistry 11(2): 396-397
Dalton, C.; Kamm, J.J.; Bartl, P. 1972: 5,5'-Diphenyl-2-thiohydantoin (DPTH): an inducer of microsomal drug-metabolizing enzymes. Journal of Pharmacology and Experimental Therapeutics 182(3): 491-499
Smith, P.J.; Surks, M.I. 1984: 5,5'-Diphenylhydantoin (dilantin) decreases cytosol and specific nuclear 3,5,3'-triiodothyronine binding in rat anterior pituitary in vivo and in cultured GC cells. Endocrinology 115(1): 283-290
Mann, D.N.; Surks, M.I. 1983: 5,5'-Diphenylhydantoin decreases specific 3,5,3'-triiodothyronine (T3) binding by rat hepatic nuclear T3 receptors. Endocrinology 112(5): 1723-1731
Tallet, F.; Coulhon, M.P.; Yonger, J.; Agneray, J.; Raichvarg, D. 1984: 5,5'-Dithiobis(2-nitrobenzoic acid) does not influence isolation or lipid composition of lipoproteins obtained by ultracentrifugation. Clinical Chemistry 30(10): 1713-1714
Colwell, W.T.; Lange, J.H.; Henry, D.W. 1968: 5,5-Diarylpenta-2,4-dienoic acid amides as potential antimalarial agents. Journal of Medicinal Chemistry 11(4): 749-752
Pakszys, W. 1973: 5,5-Diphenylhydantoin (hydantoinal Polfa). Neurologia i Neurochirurgia Polska 7(1): 79-84
Lange, J.H.; Colwell, W.T.; Henry, D.W. 1969: 5,5-diarylpenta-2,4-dienoic acid amides as potential antimalarial agents. II. Journal of Medicinal Chemistry 12(5): 946-947
Mörsdorf, K.; Wengenroth, H. 1970: 5,5-diphenyl-2-(2'-piperidinoethyl)-1,3-dioxolane-4-one a new drug with potent spasmolytic activity. Pharmacology 3(4): 193-200
Crooks, P.A.; Szyndler, R.; Cox, B. 1980: 5,6- and 6,7-dihydroxyspiro (tetralin-1,3'-pyrrolidine): conformationally restricted analogues of dopamine. Pharmaceutica Acta Helvetiae 55(5): 134-137
Wagner-Jauregg, T.; Fischer, J.; Demolis, A. 1972: 5,6-Dichloro-2-hydroxymethyl-benzimidazole (DHB), a vitamin B 6 antagonist and synergist. Arzneimittel-Forschung 22(8): 1324-1328
Martin, J.R.; Egan, R.S. 1970: 5,6-Dideoxy-5-oxoerythronolide B, a shunt metabolite of erythromycin biosynthesis. Biochemistry 9(17): 3439-3445
Trepanier, D.L.; Sprancmanis, V.; Eble, J.N. 1966: 5,6-Dihydro-4H-1,3,4-oxadiazines. V. Base-catalyzed cyclodehydrohalogenation of 2-(beta-chloroalkyl)carboxylic acid hydrazides. Journal of Medicinal Chemistry 9(5): 753-758
Krajewska, E.; Shugar, D. 1972: 5,6-Dihydro-5,6-cyclobutanyluracils and their nucleosides: intermediates in the photochemical dealkylation of 5-propyl- and 5-isopropyl uracils and their nucleosides. Acta Biochimica Polonica 19(3): 207-226
Blank, C.L.; Kissinger, P.T.; Adams, R.N. 1972: 5,6-Dihydroxyindole formation from oxidized 6-hydroxydopamine. European Journal of Pharmacology 19(3): 391-394
Fuller, R.W.; Roush, B.W. 1974: 5,6-Dihydroxytryptamine is a substrate for catechol O-methyltransferase. Biochemical Pharmacology 23(15): 2208-2209
Clineschmidt, B.V. 1973: 5,6-Dihydroxytryptamine: suppression of the anorexigenic action of fenfluramine. European Journal of Pharmacology 24(3): 405-409
Andreani, A.; Rambaldi, M.; Bonazzi, D.; Greci, L. 1980: 5,6-Disubstituted imidazo-[2,1-b]thiazoles with potential inflammatory activity. Bollettino Chimico Farmaceutico 119(11): 647-652
Demple, B.; Linn, S. 1982: 5,6-Saturated thymine lesions in DNA: production by ultraviolet light or hydrogen peroxide. Nucleic Acids Research 10(12): 3781-3789
Laub, O.; Jakobovits, E.B.; Aloni, Y. 1980: 5,6-dichloro-1-beta-ribofuranosylbenzimidazole enhances premature termination of late transcription of simian virus 40 DNA. Proceedings of the National Academy of Sciences of the United States of America 77(6): 3297-3301
Trepanier, D.L.; Krieger, P.E.; Mennear, J.H.; Eble, J.N. 1967: 5,6-dihydro-4H-1,3,4-thiadiazines. 3. Chemistry and pharmacology of a series of basic derivatives. Journal of Medicinal Chemistry 10(6): 1085-1087
Sullivan, L.J.; Eldridge, J.M.; Knaak, J.B.; Tallant, M.J. 1972: 5,6-dihydro-5,6-dihydroxycarbaryl glucuronide as a significant metabolite of carbaryl in the rat. Journal of Agricultural and Food Chemistry 20(5): 980-985
Minard, F.N.; Grant, D.S. 1970: 5,6-dihydrouracil: its occurrence and metabolism in rat brain. Biochimica et Biophysica Acta 209(1): 255-257
Saeki, H.; Oki, E. 1968: 5,6-epimino-D-glucofuranose and synthesis of nojirimycin (5-amino-5-deoxyglucose). Chemical and Pharmaceutical Bulletin 16(12): 2477-2481
McCormick, A.M.; Napoli, J.L.; Yoshizawa, S.; DeLuca, H.F. 1980: 5,6-epoxyretinoic acid is a physiological metabolite of retinoic acid in the rat. Biochemical Journal 186(2): 475-481
Koshihara, Y.; Murota, S.; Nicolaou, K.C. 1983: 5,6-methano leukotriene A4: a potent specific inhibitor for 5-lipoxygenase. Advances in Prostaglandin Thromboxane and Leukotriene Research 11: 163-167
Carissimi, M.; De Meglio, P.G.; Ravenna, F.; Riva, G. 1969: 5,7-Dichloro-8-hydroxy-quinoline derivatives with antibacterial and antifungal activity. Il Farmaco; Edizione Scientifica 24(5): 478-499
Cannon, J.G.; Brubaker, A.N.; Long, J.P.; Flynn, J.R.; Verimer, T.; Harnirattisai, P.; Costall, B.; Naylor, R.J.; Nohria, V. 1981: 5,7-Dihydroxy-2-aminotetralin derivatives: synthesis and assessment of dopaminergic and adrenergic actions. Journal of Medicinal Chemistry 24(2): 149-153
Daly, J.; Fuxe, K.; Jonsson, G. 1974: 5,7-Dihydroxytryptamine as a tool for the morphological and functional analysis of central 5-hydroxytryptamine neurons. Research Communications in Chemical Pathology and Pharmacology 7(1): 175-187
Carter, C.J.; Pycock, C.J. 1980: 5,7-Dihydroxytryptamine lesions of the amygdala reduce amphetamine- and apomorphine-induced stereotyped behaviour in the rat. Naunyn-Schmiedeberg's Archives of Pharmacology 312(3): 235-238
Villalobos, A.; Butler, T.W.; Chapin, D.S.; Chen, Y.L.; DeMattos, S.B.; Ives, J.L.; Jones, S.B.; Liston, D.R.; Nagel, A.A.; Nason, D.M. 1995: 5,7-dihydro-3-[2-[1-(phenylmethyl)-4-piperidinyl]ethyl]-6H- pyrrolo[3,2-f]-1,2-benzisoxazol-6-one: a potent and centrally-selective inhibitor of acetylcholinesterase with an improved margin of safety. Journal of Medicinal Chemistry 38(15): 2802-2808
Baumgarten, H.G.; Lachenmayer, L. 1972: 5,7-dihydroxytryptamine: improvement in chemical lesioning of indoleamine neurons in the mammalian brain. Zeitschrift für Zellforschung und mikroskopische Anatomie 135(3): 399-414
Atkinson, J.P.; Simchowitz, L.; Mehta, J.; Stenson, W.F. 1982: 5,8,11,14-Eicosatetraynoic acid (ETYA) inhibits binding of N-formyl-methionyl-leucyl-phenylalanine (FLMP) to its receptor on human granulocytes. A note of caution. Immunopharmacology 4(1): 1-9
Sarges, R.; Tretter, J.R.; Tenen, S.S.; Weissman, A. 1973: 5,8-Disubstituted 1-aminotetralins. A class of compounds with a novel profile of central nervous system activity. Journal of Medicinal Chemistry 16(9): 1003-1011
Remers, W.A.; Greenblatt, E.N.; Ellenbogen, L.; Weiss, M.J. 1971: 5,8-dihydroharman derivatives. their preparation and biological activities. Journal of Medicinal Chemistry 14(4): 331-335
Hausen, B.M.; Schmalle, H.W.; Marshall, D.; Thomson, R.H. 1983: 5,8-dihydroxyflavone (primetin) the contact sensitizer of Primula mistassinica Michaux. Archives of Dermatological Research 275(6): 365-370
Malesani, G.; Pietrogrande, A.; Rodighiero, G. 1968: 5,8-dioxyquinazoline derivates. Il Farmaco; Edizione Scientifica 23(8): 765-777
Madejczyk, A.; Golebiowska, D.; Leszczyńska, H.; Nowak, G.; Pieńkowska, F. 1968: 5- and 10-years survival in lymphogranulomatosis. Nowotwory 18(3): 245-250
Domagalina, E.; Ochyńska, J. 1974: 5- and 6-aminoacetamidophtalazine-1,4-dione derivatives. Polish Journal of Pharmacology and Pharmacy 26(4): 473-477
Ho, Y.K.; Hakala, M.T.; Zakrzewski, S.F. 1972: 5-(1-Adamantyl) pyrimidines as inhibitors of folate metabolism. Cancer Research 32(5): 1023-1028
Welstead, W.J.; Helsley, G.C.; Taylor, C.R.; Turnbull, L.B.; DaVanzo, J.P.; Funderburk, W.H.; Alphin, R.S. 1973: 5-(2-Aminoethyl)-2-oxazolidinones with central nervous system depressant and antiinflammatory activity. Journal of Medicinal Chemistry 16(10): 1129-1132
Miles, E.W.; Fales, H.M.; Gin, J.B. 1972: 5-(2-Chloroethyl)-3-hydroxy-2-methyl-4-pyridinecarboxaldehyde ( 5 -pyridoxal methyl chloride) and its reaction with N -acetyl-L-lysine to form a new cyclic imino acid derivative of homopyridoxal. Biochemistry 11(26): 4945-4953
Finklestein, J.Z.; Albo, V.; Ertel, I.; Karon, M.; Hammond, D. 1972: 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of advanced acute lymphocytic leukemia in children. Cancer ChemoTherapy Reports 56(4): 523-526
Moertel, C.G.; Reitemeier, R.J.; Hahn, R.G.; Schutt, A.J. 1970: 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with gastrointestinal carcinoma. Cancer ChemoTherapy Reports 54(6): 471-473
Frei, E.; Luce, J.K.; Talley, R.W.; Vaitkevicius, V.K.; Wilson, H.E. 1972: 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of lymphoma. Cancer ChemoTherapy Reports 56(5): 667-670
Kingra, G.S.; Comis, R.; Olson, K.B.; Horton, J. 1971: 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of malignant tumors other than melanoma. Cancer ChemoTherapy Reports 55(3): 281-283
Carter, S.K.; Friedman, M.A. 1972: 5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)--a new antitumor agent with activity against malignant melanoma. European Journal of Cancer 8(1): 85-92
Kolar, G.F.; Maurer, M.; Wildschütte, M. 1980: 5-(3-Hydroxymethyl-3-methyl-1-triazeno imidazole-4-carboxamide is a metabolite of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DIC, DTIC NSC-45388). Cancer Letters 10(3): 235-241
Kropinski, A.M.; Bose, R.J.; Warren, R.A. 1973: 5-(4-Aminobutylaminomethyl)uracil, an unusual pyrimidine from the deoxyribonucleic acid of bacteriophage phiW-14. Biochemistry 12(1): 151-157
Rehse, K.; Kapp, W.D. 1982: 5-(Amidinobenzyl) barbituric acids that are analogous to 3-(4-amidinophenyl) pyruvic acid. Archiv der Pharmazie 315(4): 346-353
Villani, F.J.; Mann, T.A. 1968: 5-(Dimethylaminopropyl)-19,11-dihydro-5H-benzo[2,3]pyrido[6,7-b]azepine. Journal of Medicinal Chemistry 11(4): 894-896
Smith, C.W.; Walter, R.; Stavropoulos, G.; Theodoropoulos, D. 1980: 5-(N4,N4-Dimethylasparagine),8-lysine]vasopressin: the first 5-position neurohypophyseal hormone analogue to retain to retain significant antidiuretic potency. Journal of Medicinal Chemistry 23(2): 217-219
Harris, R.A.; McCune, S.A. 1981: 5-(Tetradecyloxy)-2-furoic acid. Methods in Enzymology 72: 552-559
Yamada, Y.; Murao, K.; Ishikura, H. 1981: 5-(carboxymethylaminomethyl)-2-thiouridine, a new modified nucleoside found at the first letter position of the anticodon. Nucleic Acids Research 9(8): 1933-1939
Doody, M.C.; Gotto, A.M.; Smith, L.C. 1982: 5-(dimethylamino)naphthalene-1-sulfonic acid, a fluorescent probe of the medium chain fatty acid binding site of serum albumin. Biochemistry 21(1): 28-33
Jezek, P.; Nezval, J. 1967: 5-(p-aminophenyl)-cytosine compared with various antibiotics in the therapy of tick-borne encephalitis. Zentralblatt für Bakteriologie Parasitenkunde Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-Hygienische Bakteriologie Virusforschung und Parasitologie. Originale 202(1): 27-32
Tomita, K.; Tawa, A.; Doi, S.; Yumura, K.; Ikeda, T.; Toyoshima, K.; Nishida, M. 1983: 5-10 year follow-up of children who have recovered from bronchial asthma. Arerugi 32(3): 158-163
Nöthiger, F.; Ghazal, R.; Deucher, F.; Fehr, H. 1974: 5-10 years after vagotomy and antrectomy - intermediate results in 111 patients. Helvetica Chirurgica Acta 41(1-2): 131-137
De Grouchy, J.; Gabilan, J.C. 1965: 5-21-22 translocation and the crying cat syndrome. Annales de Genetique 8(1): 31-38
Koeppe, R.E.; Schoenborn, B.P. 1984: 5-A Fourier map of gramicidin a phased by deuterium-hydrogen solvent difference neutron diffraction. Biophysical Journal 45(3): 503-507
Varela, E. 1994: 5-ASA versus sulfasalazine. Acta Gastroenterologica Latinoamericana 25(5): 317-319
McLean, R.; Beidler, J. 1969: 5-Acetamido-3,5-dideoxy-D-galacto-octulosonic acid, an eight-carbon analog of N-acetylneuraminic acid. Journal of the American Chemical Society 91(19): 5388
Punnose, J.; Mathew, K.S.; Ahmed, H.F. 1995: 5-Alpha-reductase deficiency in a Saudi "girl". Postgraduate Medical Journal 71(841): 701
Shigesada, K.; Ebisuno, T.; Katsuki, H. 1970: 5-Amino-4-hydroxyvaleric acid: a new intermediate in 5-aminolevulinate metabolism of Rhodospirillum rubrum. Biochemical and Biophysical Research Communications 39(1): 135-141
Eiden, F.; Leister, H.P.; Mayer, D. 1983: 5-Aminoacetamido-4,6-dimethyl-2-hydroxy-isophthalic acid diethyl ester: synthesis and investigation of antiarrhythmic properties. 92. Studies of pyran derivatives. Arzneimittel-Forschung 33(1): 101-105
Khan, A.H. 1968: 5-Aminoacridine induced crossing over the Drosophila male. Die Naturwissenschaften 55(2): 85-86
Vacca, L.; Lillie, R.D. 1972: 5-Aminoisophthalic acid in glacial acetic acid for introduction of carboxyl groups at periodic acid-engendered aldehyde sites. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 20(1): 79
Seehra, J.S.; Gore, M.G.; Chaudhry, A.G.; Jordan, P.M. 1981: 5-Aminolevulinic acid dehydratase. the role of sulphydryl groups in 5-aminolevulinic acid dehydratase from bovine liver. European Journal of Biochemistry 114(2): 263-269
Seehra, J.S.; Jordan, P.M. 1981: 5-Aminolevulinic acid dehydratase: alkylation of an essential thiol in the bovine-liver enzyme by active-site-directed reagents. European Journal of Biochemistry 113(3): 435-446
Fanica-Gaignier, M.; Clement-Metral, J. 1973: 5-Aminolevulinic-acid synthetase of Rhodopseudomonas spheroides Y. Kinetic mechanism and inhibition by ATP. European Journal of Biochemistry 40(1): 19-24
Fanica-Gaignier, M.; Clement-Metral, J. 1973: 5-Aminolevulinic-acid synthetase of Rhodopseudomonas spheroides Y. Purification and some properties. European Journal of Biochemistry 40(1): 13-18
René, E.; Farinotti, R.; Mignon, M.; Cerf, M.; Dauphin, A.; Bonfils, S. 1983: 5-Aminosalicylic acid enema preparation. Gastroenterologie Clinique et Biologique 7(11): 935
Jones, R.W.; Allan, L.D.; Tynan, M.J.; Joseph, M.C. 1982: Ultrasound diagnosis of cerebral arteriovenous malformation in the newborn. Lancet 1(8263): 102-103
Bondesen, S.; Nielsen, O.H.; Jacobsen, O.; Rasmussen, S.N.; Hansen, S.H.; Halskov, S.; Binder, V.; Hvidberg, E.F. 1984: 5-Aminosalicylic acid enemas in patients with active ulcerative colitis. Influence of acidity on the kinetic pattern. Scandinavian Journal of Gastroenterology 19(5): 677-682
Trallori, G.; Messori, A.; Scuffi, C.; Bardazzi, G.; Silvano, R.; d'Albasio, G.; Pacini, F. 1995: 5-Aminosalicylic acid enemas to maintain remission in left-sided ulcerative colitis: a meta- and economic analysis. Journal of Clinical Gastroenterology 20(3): 257-259
Dew, M.J.; Evans, B.K.; Rhodes, J. 1984: 5-Aminosalicylic acid for the treatment of inflammatory bowel disease. Gastroenterology 87(2): 480-481
Adrych, K.; Zaucha, J.M.; Kryszewski, A. 1993: 5-Aminosalicylic acid in treatment of non-specific enteritis. Wiadomosci Lekarskie 46(21-22): 833-836
Hoult, J.R.; Page, H. 1981: 5-Aminosalicylic acid, a co-factor for colonic prostacyclin synthesis?. Lancet 2(8240): 255
Kaltenbronn, J.S.; Rhee, T.O. 1968: 5-Aryl-2-furanacetic acids. Journal of Medicinal Chemistry 11(4): 902
McKenzie, T.C.; Epstein, J.W.; Fanshawe, W.J.; Dixon, J.S.; Osterberg, A.C.; Wennogle, L.P.; Regan, B.A.; Abel, M.S.; Meyerson, L.R. 1984: 5-Aryl-3-azabicyclo[3.2.0]heptan-6-one ketals, compounds with morphine-like analgesic activity. Journal of Medicinal Chemistry 27(5): 628-633
Budĕsínský, Z.; Letovský, V. 1966: 5-Aryl-pyrimidines. 3. 5-Aryl-isocytosines and 5-aryl-4-thio-isocytosines. Ceskoslovenska Farmacie 15(8): 432-437
Gangjee, A.; Devraj, R.; McGuire, J.J.; Kisliuk, R.L. 1995: 5-Arylthio-substituted 2-amino-4-oxo-6-methylpyrrolo[2,3-d]pyrimidine antifolates as thymidylate synthase inhibitors and antitumor agents. Journal of Medicinal Chemistry 38(22): 4495-4502
Pinto, A.; Zagonel, V. 1993: 5-Aza-2'-deoxycytidine (Decitabine) and 5-azacytidine in the treatment of acute myeloid leukemias and myelodysplastic syndromes: past, present and future trends. Leukemia 7(Suppl 1): 51-60
Zagonel, V.; Lo Re, G.; Marotta, G.; Babare, R.; Sardeo, G.; Gattei, V.; De Angelis, V.; Monfardini, S.; Pinto, A. 1993: 5-Aza-2'-deoxycytidine (Decitabine) induces trilineage response in unfavourable myelodysplastic syndromes. Leukemia 7(Suppl 1): 30-35
Caraglia, M.; Pinto, A.; Correale, P.; Zagonel, V.; Genua, G.; Leardi, A.; Pepe, S.; Bianco, A.R.; Tagliaferri, P. 1994: 5-Aza-2'-deoxycytidine induces growth inhibition and upregulation of epidermal growth factor receptor on human epithelial cancer cells. Annals of Oncology: Official Journal of the European Society for Medical Oncology 5(3): 269-276
Pinto, A.; Attadia, V.; Fusco, A.; Ferrara, F.; Spada, O.A.; Di Fiore, P.P. 1984: 5-Aza-2'-deoxycytidine induces terminal differentiation of leukemic blasts from patients with acute myeloid leukemias. Blood 64(4): 922-929
Veselý, J.; Cihák, A. 1980: 5-Aza-2'-deoxycytidine: preclinical studies in mice. Neoplasma 27(2): 113-119
Heller, P.; DeSimone, J. 1984: 5-Azacytidine and fetal hemoglobin. American Journal of Hematology 17(4): 439-447
Peterson, B.A.; Collins, A.J.; Vogelzang, N.J.; Bloomfield, C.D. 1981: 5-Azacytidine and renal tubular dysfunction. Blood 57(1): 182-185
Halle, S. 1968: 5-Azacytidine as a mutagen for arboviruses. Journal of Virology 2(10): 1228-1229
Dover, G.J.; Charache, S.H.; Boyer, S.H.; Talbot, C.C.; Smith, K.D. 1983: 5-Azacytidine increases fetal hemoglobin production in a patient with sickle cell disease. Progress in Clinical and Biological Research 134: 475-488
Ley, T.J.; DeSimone, J.; Noguchi, C.T.; Turner, P.H.; Schechter, A.N.; Heller, P.; Nienhuis, A.W. 1983: 5-Azacytidine increases gamma-globin synthesis and reduces the proportion of dense cells in patients with sickle cell anemia. Blood 62(2): 370-380
Zucker, R.M.; Decal, D.L.; Whittington, K.B. 1983: 5-Azacytidine increases the synthesis of embryonic hemoglobin (E2) in murine erythroleukemic cells. Febs Letters 162(2): 436-441
Walker, C.; Shay, J.W. 1984: 5-Azacytidine induced myogenesis in a differentiation defective cell line. Differentiation; Research in Biological Diversity 25(3): 259-263
Niwa, O.; Sugahara, T. 1981: 5-Azacytidine induction of mouse endogenous type C virus and suppression of DNA methylation. Proceedings of the National Academy of Sciences of the United States of America 78(10): 6290-6294
Konieczny, S.F.; Emerson, C.P. 1984: 5-Azacytidine induction of stable mesodermal stem cell lineages from 10T1/2 cells: evidence for regulatory genes controlling determination. Cell 38(3): 791-800
DeSimone, J.; Heller, P.; Hall, L.; Zwiers, D. 1982: 5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons. Proceedings of the National Academy of Sciences of the United States of America 79(14): 4428-4431
Taylor, S.M.; Constantinides, P.A.; Jones, P.A. 1984: 5-Azacytidine, DNA methylation, and differentiation. Current Topics in Microbiology and Immunology 108: 115-127
Sorm, F.; Pískala, A.; Cihák, A.; Veselý, J. 1964: 5-Azacytidine, a new, highly effective cancerostatic. Experientia 20(4): 202-203
Clough, D.W.; Kunkel, L.M.; Davidson, R.L. 1982: 5-Azacytidine-induced reactivation of a herpes simplex thymidine kinase gene. Science 216(4541): 70-73
Walker, C.; Ranney, D.F.; Shay, J.W. 1984: 5-Azacytidine-induced uncoupling of differentiation and tumorigenicity in a murine cell line. Journal of the National Cancer Institute 73(4): 877-885
Schmid, M.; Haaf, T.; Grunert, D. 1984: 5-Azacytidine-induced undercondensations in human chromosomes. Human Genetics 67(3): 257-263
Carr, B.I.; Reilly, J.G.; Riggs, A.D. 1984: 5-Azacytidine. Promoting activity for rat hepatocellular carcinoma. Iarc Scientific Publications 56: 409-412
Karon, M.; Sieger, L.; Leimbrock, S.; Finklestein, J.Z.; Nesbit, M.E.; Swaney, J.J. 1973: 5-Azacytidine: a new active agent for the treatment of acute leukemia. Blood 42(3): 359-365
Napier, M.L.; Hardman, J.K. 1984: 5-Azidoindole binding to the Escherichia coli tryptophan synthase alpha 2 beta 2 complex. Archives of Biochemistry and Biophysics 234(1): 206-213
Kondratiev YuS; Skavronskaya, A.G. 1971: 5-BU sensitization to UV-induced killing and mutability in hcr + and hcr - strains of Escherichia coli. Mutation Research 12(1): 105-108
Carson, J.R.; McKinstry, D.N.; Wong, S. 1971: 5-Benzoyl-1-methylpyrrole-2-acetic acids as antiinflammatory agents. Journal of Medicinal Chemistry 14(17): 646-647
Carson, J.R.; Wong, S. 1973: 5-Benzoyl-1-methylpyrrole-2-acetic acids as antiinflammatory agents. 2. the 4-methyl compounds. Journal of Medicinal Chemistry 16(2): 172-174
Ito, F.; Sartwell, A.D.; Chou, J.Y. 1984: 5-Bromo-2'-deoxyuridine induces placental alkaline phosphatase biosynthesis in cultured choriocarcinoma cells. Archives of Biochemistry and Biophysics 233(2): 830-837
Freeman, A.E.; Gilden, R.V.; Vernon, M.L.; Wolford, R.G.; Hugunin, P.E.; Huebner, R.J. 1973: 5-Bromo-2'-deoxyuridine potentiation of transformation of rat-embryo cells induced in vitro by 3-methylcholanthrene: induction of rat leukemia virus gs antigen in transformed cells. Proceedings of the National Academy of Sciences of the United States of America 70(8): 2415-2419
Itoi, M. 1973: 5-Bromo-2'deoxyuridine and experimental congenital cataract. Nippon Ganka Gakkai Zasshi 77(11): 1962-1963
Ali, S.L. 1974: 5-Bromo-2-ethoxybenzamide. Pharmaceutica Acta Helvetiae 49(7-8): 266-267
Zakharov, A.F.; Bairamjan, T.L. 1980: 5-Bromodeoxycytidine in the study of sister chromatid exchanges in human lymphocytes. Human Genetics 55(2): 259-263
Achour, A.; Biquard, J.M.; Vigier, P.; Blanchet, J.P. 1980: 5-Bromodeoxyuridine augmentation of the expression, on chick embryo fibroblasts of a cellular antigen present on avian oncoviruses. Comptes Rendus des Seances de l'Academie des Sciences. Serie D Sciences Naturelles 291(2): 233-236
Calothy, G.; Hirai, K.; Defendi, V. 1973: 5-Bromodeoxyuridine incorporation into simian virus 40 deoxyribonucleic acid. Effects on simian virus 40 replication in monkey cells. Virology 55(2): 329-338
O'Neill, M.C.; Stockdale, F.E. 1974: 5-Bromodeoxyuridine inhibition of differentiation. Kinetics of inhibition and reversal in myoblasts. Developmental Biology 37(1): 117-132
Garcia, M.; Westley, B.; Rochefort, H. 1981: 5-Bromodeoxyuridine specifically inhibits the synthesis of estrogen-induced proteins in MCF7 cells. European Journal of Biochemistry 116(2): 297-301
Jacob, M. 1982: 5-Bromodeoxyuridine substitution and differential radiosensitivity of uni- and bi-filar chromatids. Mutation Research 103(2): 173-176
King, M.T.; Wild, D.; Gocke, E.; Eckhardt, K. 1982: 5-Bromodeoxyuridine tablets with improved depot effect for analysis in vivo of sister-chromatid exchanges in bone-marrow and spermatogonial cells. Mutation Research 97(2): 117-129
Pasztor, L.M.; Hu, F.; McNulty, W.P. 1973: 5-Bromodeoxyuridine-tolerant melanoma cells in vitro and in vivo. Yale Journal of Biology and Medicine 46(5): 397-410
Grippo, P.; Siracusa, G.; Orlando, P.; Locorotondo, G. 1981: 5-Bromouracil DNA glycosylase activity in differentiating muscle cells. Cell Biology International Reports 5(6): 552
Kakkar, R.K. 1967: 5-Bromouracil and induced production of fusaric acid by Fusarium oxysporum f. lycopersici in culture. Experientia 23(6): 441-443
Bishop, R.J.; Sueoka, N. 1972: 5-Bromouracil-tolerant mutants of Bacillus subtilis. Journal of Bacteriology 112(2): 870-876
Jones, R.J.; Thompson, D.P. 1974: 5-Bromouridylyl-(3-5)-adenosine isolated from 5-bromouracil-induced filaments of Escherichia coli. Journal of Bacteriology 120(2): 831-836
Lis, A.W.; McLaughlin, R.K.; McLaughlin, D.L.; Daves, G.D.; Anderson, W.R. 1973: 5-Chlorocytosine. Occurrence in salmon sperm deoxyribonucleic acid. Journal of the American Chemical Society 95(17): 5789-5790
Barrio, J.R.; del Carmen, M.; Barrio, G.; Vernengo, M.J. 1971: 5-Cyclohexylmethyl-5-arylhydantoins. Journal of Medicinal Chemistry 14(9): 898
Semovo, N.; Strashimirova, T.; Damianova, R.; Pavlova, P.; Bircheva, E. 1982: 5-Day academic week and the functional status of pupils in the beginning classes. Gigiena i Sanitariia 8: 70-72
Seiler, N.; Schmidt-Glenewinkel, T.; Schneider, H.H. 1973: 5-Di-n-butylaminonaphthalene-1-sulphonyl chloride--A new reagent for fluorescence labelling of amines, amino acids and peptides. Journal of Chromatography 84(1): 95-107
Fiedler, H.; Hahn von Dorsche, H. 1970: 5-Diazonium-1 H-tetrazole--a new reagent for the histochemical demonstration of histidine. Acta Histochemica 35(2): 414-416
Cardin, A.D.; Jackson, R.L.; Johnson, J.D. 1982: 5-Dimethylaminonaphthalene-1-sulfonyl 3-aminotyrosyl apolipoprotein C-III. Preparation, characterization, and interaction with phospholipid vesicles. Journal of Biological Chemistry 257(9): 4987-4992
Majumder, K.; Selvapandiyan, A.; Fattah, F.A.; Arora, N.; Ahmad, S.; Bhatnagar, R.K. 1995: 5-Enolpyruvylshikimate-3-phosphate synthase of Bacillus subtilis is an allosteric enzyme. Analysis of Arg24-->Asp, Pro105-->Ser and His385-->Lys mutations suggests a hidden phosphoenolpyruvate-binding site. European Journal of Biochemistry 229(1): 99-106
Steinrücken, H.C.; Amrhein, N. 1984: 5-Enolpyruvylshikimate-3-phosphate synthase of Klebsiella pneumoniae 2. Inhibition by glyphosate [N-(phosphonomethyl)glycine. European Journal of Biochemistry 143(2): 351-357
Steinrücken, H.C.; Amrhein, N. 1984: 5-Enolpyruvylshikimate-3-phosphate synthase of Klebsiella pneumoniae. 1. Purification and properties. European Journal of Biochemistry 143(2): 341-349
Singh, S.; Willers, I.; Goedde, H.W. 1974: 5-Ethyl-2'-deoxyuridine: absence of effects on the chromosomes of human lymphocytes and fibroblasts in culture. Humangenetik 24(2): 135-139
Swierkowska, K.M.; Jasińska, J.K.; Steffen, J.A. 1973: 5-Ethyl-2'-deoxyuridine: evidence for incorporation into DNA and evaluation of biological properties in lymphocyte cultures grown under conditions of amethopterine-imposed thymidine deficiency. Biochemical Pharmacology 22(1): 85-93
Pietrzykowska, I.; Shugar, D. 1968: 5-Ethyldeoxyuridine, a thymidine analog: photochemical transformation. Science 161(3847): 1248-1249
Kroener, J.F.; Saleh, F.; Howell, S.B. 1982: 5-FU and allopurinol: toxicity modulation and phase Ii results in colon cancer. Cancer Treatment Reports 66(5): 1133-1137
Sanani, S.; Spaulding, M.B.; Masud, A.R.; Canty, R. 1981: 5-FU cardiotoxicity. Cancer Treatment Reports 65(11-12): 1123-1125
Nogaki, H.; Taomoto, K.; Tamaki, N.; Matsumoto, S. 1983: 5-FU concentration in brain tumors after co-administration of FT and uracil. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 10(4 Part 1): 1007-1012
Suzuki, M.; Aida, I.; Ohwada, M.; Sato, I.; Tamura, T.; Kasuga, Y. 1995: 5-FU concentrations in the blood and tumor tissue after 5'-DFUR or UFT administration in the patients with uterine cervical cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(2): 253-258
Carlberger, G.; Ljungdahl, I. 1971: 5-FU excretion in anticarcinogenic therapy in liver cancer. Nordisk Medicin 86(46): 1360
Ruddick, J.A.; Runner, M.N. 1974: 5-FU in chick embryos as a source of label for DNA and a depressant of protein synthesis. Teratology 10(1): 39-45
Havsteen, H.; Sörenson, S.; Rørth, M.; Dombernowsky, P.; Hansen, H.H. 1981: 5-FU in the treatment of small cell anaplastic carcinoma of the lung: a phase Ii trial. Cancer Treatment Reports 65(1-2): 123-125
Biran, H.; Sulkes, A.; Biran, S. 1981: 5-FU, methotrexate, and mitomycin in advanced colorectal adenocarcinoma: a phase Ii study. Cancer Treatment Reports 65(9-10): 924-925
Brunner, J.; Engeler, V. 1974: 5-Flour-ocytosin as treatment agent in genital mycosis. Schweizerische Rundschau für Medizin Praxis 63(48): 1450-1454
Foster, A.B.; Jarman, M.; Kinas, R.W.; van Maanen, J.M.; Taylor, G.N.; Gaston, J.L.; Parkin, A.; Richardson, A.C. 1981: 5-Fluoro- and 5-chlorocyclophosphamide: synthesis, metabolism, and antitumor activity of the cis and trans isomers. Journal of Medicinal Chemistry 24(12): 1399-1403
Kufe, D.W.; Major, P.P.; Egan, E.M.; Loh, E. 1981: 5-Fluoro-2'-deoxyuridine incorporation in L1210 DNA. Journal of Biological Chemistry 256(17): 8885-8888
Tommerup, N.; Poulsen, H.; Brøndum-Nielsen, K. 1981: 5-Fluoro-2'-deoxyuridine induction of the fragile site on Xq28 associated with X linked mental retardation. Journal of Medical Genetics 18(5): 374-376
Santi, D.V.; McHenry, C.S. 1972: 5-Fluoro-2'-deoxyuridylate: covalent complex with thymidylate synthetase. Proceedings of the National Academy of Sciences of the United States of America 69(7): 1855-1857
Utz, J.P.; Tynes, B.S.; Shadomy, H.J.; Duma, R.J.; Kannan, M.M.; Mason, K.N. 1968: 5-Fluorocytosine in human cryptococcosis. Antimicrobial Agents and ChemoTherapy 8: 344-346
Oftebro, R.; Grimmer, O.; Oyen, T.B.; Laland, S.G. 1972: 5-Fluoropyrimidin-2-one, a new metaphase arresting agent. Biochemical Pharmacology 21(18): 2451-2456
Bean, B.; Tomasz, A. 1973: 5-Fluoropyrimidine-resistant mutants of pneumococcus. Journal of Bacteriology 113(3): 1348-1355
Van Eden, E.B.; Falkson, G.; van Dyk, J.J.; van der Merwe, A.M.; Falkson, H.C. 1972: 5-Fluorouracil (5-Fu; NSC-19893), 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388), vincristine (NSC-67574), and 1,3-bis(2-chloroethyl)-2-nitrosourea (BCNU; NSC-409962) given concomitantly in the treatment of solid tumors in man. Cancer ChemoTherapy Reports 56(1): 107-147
Valeriote, F.; Santelli, G. 1984: 5-Fluorouracil (FUra). Pharmacology and Therapeutics 24(1): 107-132
Land, V.J.; Dyment, P.G.; Komp, D.; Humphrey, G.B.; Sullivan, M.P.; Starling, K.A. 1973: 5-Fluorouracil (NSC-19893) and actinomycin D (NSC-3053) in the treatment of acute leukemic in children. Cancer ChemoTherapy Reports 57(3): 335-339
Cressy, N.L.; Schell, H.W. 1966: 5-Fluorouracil (NSC-19893) in glucose and saline: therapeutic effect and toxicity. Cancer ChemoTherapy Reports 50(9): 683-684
Friedman, M.A.; Marcus, F.S.; Cassidy, M.J.; Resser, K.J.; Kohler, M.; Hendrickson, C.G.; Reynolds, R.; Johnson, D.; Kilbridge, T.; Yu, K.; Cruicitt, M. 1983: 5-Fluorouracil + Oncovin + Adriamycin + mitomycin C (FOAM): an effective program for breast cancer, even for disease refractory to previous chemotherapy. A Northern California Oncology Group (NCOG) Study. Cancer 52(2): 193-197
Levin, V.A.; Edwards, M.S.; Wara, W.M.; Allen, J.; Ortega, J.; Vestnys, P. 1984: 5-Fluorouracil and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) followed by hydroxyurea, misonidazole, and irradiation for brain stem gliomas: a pilot study of the Brain Tumor Research Center and the Childrens Cancer Group. Neurosurgery 14(6): 679-681
Trnka, J. 1972: 5-Fluorouracil and Bucky rays in the treatment of superficial basaliomas. Ceskoslovenska Dermatologie 47(2): 80-82
Shinohara, N.; Harabayashi, T.; Matsuda, H.; Nounaka, O.; Nonomura, K.; Koyanagi, T.; Nagomori, S.; Ohmuro, H.; Matsumara, K.; Demura, T. 1995: 5-Fluorouracil and alpha-2a interferon in patients with hormone-refractory prostate cancer. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 86(10): 1557-1562
Jato, J.; Windheuser, J.J. 1973: 5-Fluorouracil and derivatives in cancer chemotherapy. 3. in vivo enhancement of antitumor activity of 5-fluorouracil (FU) and 5-fluoro-2'-deoxyuridine (FUDR). Journal of Pharmaceutical Sciences 62(12): 1975-1978
Windheuser, J.J.; Jato, J. 1972: 5-Fluorouracil and derivatives in cancer chemotherapy. II. Possible in vivo formation and stabilization of 5-fluoro-2'-deoxyuridine. Journal of Pharmaceutical Sciences 61(10): 1669-1670
Cunningham, J.; Bukowski, R.M.; Budd, G.T.; Weick, J.K.; Purvis, J. 1984: 5-Fluorouracil and folinic acid: a Phase I-Ii trial in gastrointestinal malignancy. Investigational new Drugs 2(4): 391-395
Mulder, J.H.; Smink, T.; van Putten, L.M. 1981: 5-Fluorouracil and methotrexate combination chemotherapy: the effect of drug scheduling. European Journal of Cancer and Clinical Oncology 17(7): 831-837
Papaioannou, A.N. 1970: 5-Fluorouracil and radiotherapy for gastrointestinal cancer. Lancet 1(7641): 304
Milstein, H.G. 1981: 5-Fluorouracil as an aid in management of acne and melasma. Journal of the American Academy of Dermatology 4(1): 97-98
Nakamura, T.; Hashimoto, I.; Sawada, Y.; Mikami, J.; Yoshimoto, M.; Nishidai, H.; Nakanishi, Y.; Kashi, Y. 1984: 5-Fluorouracil concentration in various tissues from cancer patients after oral administration of 5-fluorouracil. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(5): 1037-1048
Celio, L.A.; DiGregorio, G.J.; Ruch, E.; Pace, J.N.; Piraino, A.J. 1983: 5-Fluorouracil concentrations in rat plasma, parotid saliva, and bile and protein binding in rat plasma. Journal of Pharmaceutical Sciences 72(6): 597-599
Ozaki, S.; Watanabe, Y.; Hoshiko, T.; Ii, S.; Kagawa, T. 1983: 5-Fluorouracil derivatives. III. a simple method to prepare 5-fluoro-2'-deoxyuridine derivatives. Nucleic Acids Symposium Series 12: 9-12
Ozaki, S.; Watanabe, Y.; Hoshiko, T.; Mizuno, H.; Ishikawa, K.; Mori, H. 1984: 5-Fluorouracil derivatives. IV. Synthesis of antitumor-active acyloxyalkyl-5-fluorouracils. Chemical and Pharmaceutical Bulletin 32(2): 733-738
Houghton, J.A.; Houghton, P.J. 1980: 5-Fluorouracil in combination with hypoxathine and allopurinol: toxicity and metabolism in xenografts of human colonic carcinomas in mice. Biochemical Pharmacology 29(14): 2077-2080
Zaczek, A. 1994: 5-Fluorouracil in glaucoma surgery. Klinika Oczna 96(10-11): 329-331
Ott, F.; Storck, H. 1971: 5-Fluorouracil in local therapy of precancerous conditions and carcinoma of the skin. Schweizerische Medizinische Wochenschrift 101(34): 1243-1244
Zia, Z.F.; Wang, Y.E. 1983: 5-Fluorouracil in malignant trophoblastic tumors. report of 350 cases. Chinese Medical Journal 96(2): 121-130
Luger, A. 1969: 5-Fluorouracil in the local treatment of psoriasis. Zeitschrift für Haut- und Geschlechtskrankheiten 44(10): 361-370
Saario, I.A. 1983: 5-Fluorouracil in the treatment of acute pancreatitis. American Journal of Surgery 145(3): 349-352
Anonymous 1973: 5-Fluorouracil in the treatment of gastrointestinal neoplasia. New England Journal of Medicine 288(17): 910-912
Aran, M.; Bilge, N.; Ozman, M. 1973: 5-Fluorouracil in the treatment of gastrointestinal tumors. Turk Tip Dernegi Dergisi 39(12): 459-465
Major, P.P.; Egan, E.; Herrick, D.; Kufe, D.W. 1982: 5-Fluorouracil incorporation in DNA of human breast carcinoma cells. Cancer Research 42(8): 3005-3009
Schuetz, J.D.; Wallace, H.J.; Diasio, R.B. 1984: 5-Fluorouracil incorporation into DNA of CF-1 mouse bone marrow cells as a possible mechanism of toxicity. Cancer Research 44(4): 1358-1363
Kufe, D.W.; Major, P.P. 1981: 5-Fluorouracil incorporation into human breast carcinoma RNA correlates with cytotoxicity. Journal of Biological Chemistry 256(19): 9802-9805
Bolli, E.; Saccomanno, S.; Mondini, G.; Aschele, C.; Guglielmi, A.; Ligas, B.; Connio, M.; Mori, A.; Rosso, R.; Sobrero, A. 1995: 5-Fluorouracil plus 5-methyltetrahydrofolate in advanced pancreatic cancer. GLISP (Gruppo Ligure Studio Pancreas). Cancer ChemoTherapy and Pharmacology 35(4): 339-342
Carlsson, G.; Larsson, P.A.; Frösing, R.; Hafström, L.O.; Spears, C.P.; Peterson, A.; Gustavsson, B. 1995: 5-Fluorouracil sensitive adenocarcinoma--a new experimental model in the rat. Anticancer Research 15(2): 433-439
Kaufmann, R.; Landes, E. 1983: 5-Fluorouracil therapy following curettage of warts. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 34(10): 504-506
Shlemkevich, M.P.; Shiian, D.N. 1984: 5-Fluorouracil treatment combined with ascorbic acid in patients with disseminated stomach cancer. Vrachebnoe Delo 7: 30-32
Vinhafs, J.C.; Ferreira, A.J. 1967: 5-Fluorouracil(5-FU) in the treatment of adenocarcinomas of the digestive tract (apropos of 13 cases). Hospital (Rio de Janeiro) 71(2): 453-474
Lohrmann, H.P.; Lepp, K.A.; Schreml, W. 1982: 5-Fluorouracil, 1,3-bis(2-chloroethyl)-1-nitrosourea, and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea: effect on the human granulopoietic system. Journal of the National Cancer Institute 68(4): 541-547
Lopez, M.; Di Lauro, L.; Perno, C.F.; Papaldo, P.; Barduagni, M.; Barduagni, A. 1983: 5-Fluorouracil, adriamycin and cyclophosphamide combined with high-dose medroxyprogesterone acetate in advanced breast cancer. Tumori 69(6): 545-551
MacDonald, J.S.; Schein, P.S.; Woolley, P.V.; Smythe, T.; Ueno, W.; Hoth, D.; Smith, F.; Boiron, M.; Gisselbrecht, C.; Brunet, R.; Lagarde, C. 1980: 5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer. Annals of Internal Medicine 93(4): 533-536
McCracken, J.D.; Ray, P.; Heilbrun, L.K.; Vaitkevicius, V.K.; Saiki, J.H.; Rivkin, S.E.; Rossof, A.H.; Moore, T.N. 1980: 5-Fluorouracil, methyl-CCNU, and radiotherapy with or without testolactone for localized adenocarcinoma of the exocrine pancreas: a Southwest Oncology Group Study. Cancer 46(7): 1518-1522
Harvey, J.H.; Smith, F.P.; Schein, P.S. 1984: 5-Fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 2(11): 1245-1248
Liberati, A.M.; Di Costanzo, F.; Buzzi, F.; Fatati, G.; Biscottini, B.; Ballatori, E.; Falchi, R.; Grignani, F. 1983: 5-Fluorouracil, vincristine and hydroxyurea combination chemotherapy in metastatic colorectal cancer. Tumori 69(5): 485-487
Gasparian, S.A.; Alimov, A.T.; Itin, A.B. 1968: 5-Fluorouracil-2 C14 distribution and its regional introduction into the gastric artery (experimental study). Vestnik Akademii Meditsinskikh Nauk SSSR 23(6): 64-68
Buter, J.; Sinnige, H.A.; Sleijfer, D.T.; de Vries, E.G.; Willemse, P.H.; van der Graaf, W.T.; Verschueren, R.C.; Mulder, N.H. 1995: 5-Fluorouracil/leucovorin/interferon alpha-2a in patients with advanced colorectal cancer. Effects of maintenance therapy on remission duration. Cancer 75(5): 1072-1076
Obrecht, J.P.; Weber, W.; Cano, J.P.; Crevoisier, C.; Alberto, P.; Forgo, I.; Heintz, R.; Germano, G.H. 1981: 5-Fluorouracil: a comparative pharmacokinetic study and preliminary results of a clinical phase i study. Recent Results in Cancer Research. Fortschritte der Krebsforschung. Progres Dans les Recherches sur le Cancer 79: 101-107
Poe, M.; Benkovic, S.J. 1980: 5-Formyl- and 10-formyl-5,6,7,8-tetrahydrofolate. Conformation of the tetrahydropyrazine ring and formyl group in solution. Biochemistry 19(20): 4576-4582
Bowers, M.B. 1970: 5-H.T. metabolism in psychiatric syndromes. Lancet 2(7681): 1029
Hedner, T.; Lundborg, P. 1980: 5-HIAA Levels in brain and cerebrospinal fluid of the neonatal rat during oxygen deprivation. Neuroscience Letters 19(3): 315-318
Johansson, B.; Roos, B.E.; Wålinder, J. 1972: 5-HIAA and HVA in cerebrospinal fluid during delirium acutum. New England Journal of Medicine 286(21): 1160-1161
Johansson, B.; Roos, B.E. 1971: 5-HIAA and HVA in spinal fluid and herpes zoster oticus. New England Journal of Medicine 285(11): 637
Coleman, M. 1970: 5-HIAA in cerebrospinal fluid. Developmental Medicine and Child Neurology 12(4): 539-541
Verma, A.K.; Gupta, S.K.; Maheshwari, M.C. 1984: 5-HIAA in cerebrospinal fluid of patients with status epilepticus. Epilepsia 25(4): 499-501
Iversen, S.D. 1984: 5-HT and anxiety. Neuropharmacology 23(12b): 1553-1560
Hu, Y.; Barzilai, A.; Chen, M.; Bailey, C.H.; Kandel, E.R. 1993: 5-HT and cAMP induce the formation of coated pits and vesicles and increase the expression of clathrin light chain in sensory neurons of aplysia. Neuron 10(5): 921-929
Lattanzi, V.; Nardelli, G.M.; Giorgino, R. 1972: 5-HT and menstrual cycle. Evaluation of the variations in normal women. Bollettino della Societa Italiana di Biologia Sperimentale 48(10): 271-272
Koketsu, K.; Shirasawa, Y. 1974: 5-HT and the electrogenic sodium pump. Experientia 30(9): 1034-1035
Nash, H.L.; Wallis, D.I.; Ash, G. 1984: 5-HT antagonists and blockade of neuronal (5-HT) receptors on ganglion cells. General Pharmacology 15(4): 339-344
Sallanon, M.; Buda, C.; Janin, M.; Jouvet, M. 1982: 5-HT antagonists suppress sleep and delay its restoration after 5-HTP in p-chlorophenylalanine-pretreated cats. European Journal of Pharmacology 82(1-2): 29-35
Leach, G.D.; Fozard, J.R. 1969: 5-HT autopotentiation and drug induced changes in the 5-HT vasomotor response in the pithed rat. European Journal of Pharmacology 7(1): 14-22
Watanabe, S.; Koketsu, K. 1973: 5-HT hyperpolarization of bullfrog sympathetic ganglion cell membrane. Experientia 29(11): 1370-1372
Sakumoto, T.; Sakai, K.; Jouvet, M.; Kimura, H.; Maeda, T. 1984: 5-HT immunoreactive hypothalamic neurons in rat and cat after 5-HTP administration. Brain Research Bulletin 12(6): 721-733
Tonini, M.; Onori, L.; Lecchini, S.; Frigo, G.M.; Perucca, E.; Saltarelli, P.; Crema, A. 1983: 5-HT mediated GABA excitatory responses in the guinea-pig proximal ileum. Naunyn-Schmiedeberg's Archives of Pharmacology 324(3): 180-184
Ternaux, J.P.; Gonella, J.; Legay, C.; Faudon, M.; Barrit, M.C.; Héry, F. 1981: 5-HT metabolism in the intestinal wall of the rabbit. Journal de Physiologie 77(2-3): 319-326
Wålinder, J.; Carlsson, A.; Persson, R. 1981: 5-HT reuptake inhibitors plus tryptophan in endogenous depression. Acta Psychiatrica Scandinavica. Supplementum 290: 179-190
Anderson, P.; Slorach, S.A.; Uvnäs, B. 1974: 5-HT storage in rat and rabbit blood platelets: the separation of ATP-containing and sulphomucopolysaccharide-containing granules. Acta Physiologica Scandinavica 90(3): 522-532
Maître, L.; Baumann, P.A.; Jackel, J.; Waldmeier, P.C. 1982: 5-HT uptake inhibitors: psychopharmacological and neurobiochemical criteria of selectivity. Advances in Biochemical Psychopharmacology 34: 229-246
Wenting, G.J.; Woittiez, A.J.; Man in't Veld, A.J.; Schalekamp, M.A. 1984: 5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency. Hypertension 6(1): 100-109
Cropper, E.C.; Eisenman, J.S.; Azmitia, E.C. 1984: 5-HT-Immunoreactive fibers in the trigeminal nuclear complex of the rat. Experimental Brain Research 55(3): 515-522
Green, A.R. 1984: 5-HT-mediated behavior. Animal studies. Neuropharmacology 23(12b): 1521-1528
Van Praag, H.M. 1994: 5-HT-related, anxiety- and/or aggression-driven depression. International Clinical Psychopharmacology 9(Suppl 1): 5-6
Shannon, M.; Battaglia, G.; Glennon, R.A.; Titeler, M. 1984: 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA). European Journal of Pharmacology 102(1): 23-29
Peroutka, S.J. 1984: 5-HT1 receptor sites and functional correlates. Neuropharmacology 23(12b): 1487-1492
Rasmusson, A.M.; Goldstein, L.E.; Deutch, A.Y.; Bunney, B.S.; Roth, R.H. 1994: 5-HT1a agonist +/-8-OH-DPAT modulates basal and stress-induced changes in medial prefrontal cortical dopamine. Synapse 18(3): 218-224
Goodwin, G.M.; Green, A.R.; Johnson, P. 1984: 5-HT2 receptor characteristics in frontal cortex and 5-HT2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice. British Journal of Pharmacology 83(1): 235-242
Demoulin, J.C.; Bertholet, M.; Soumagne, D.; David, J.L.; Kulbertus, H.E. 1981: 5-HT2-receptor blockade in the treatment of heart failure. a preliminary study. Lancet 1(8231): 1186-1188
Blier, P.; Monroe, P.J.; Bouchard, C.; Smith, D.L.; Smith, D.J. 1993: 5-HT3 receptors which modulate [3H]5-HT release in the guinea pig hypothalamus are not autoreceptors. Synapse 15(2): 143-148
Hinterberger, H.; Batholomew, R.J.; Robertson, M.; Schneeweiss, J.; Hennessey, S.; Vagholkar, M.K. 1968: 5-Hdroxytryptamine in platelets and 5-hydroxyindole-acetic acid in urine in asthma and other diseases of the respiratory tract. American Review of Respiratory Disease 98(4): 707-710
Spatz, N.; Spatz, H.; Fischer, E. 1972: 5-Hydroxy-3-methylindole in the urine of epileptic patients. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 166(8): 1213
Wetzel, E.R.; Osterberg, A.C.; Borders, D.B. 1974: 5-Hydroxy-5-phenyllevulinic acid. a novel microbial metabolite with analgesic activity. Journal of Medicinal Chemistry 17(2): 249-250
Legler, G.; Ahmad, V.U. 1969: 5-Hydroxy-6-methoxy- and 5,6-dihydroxy-1-naphthylacetic acid as possible metabolite of 1-naphthylacetic acid. Zeitschrift für Naturforschung. Teil B Chemie Biochemie Biophysik Biologie und verwandte Gebiete 24(6): 784-785
Hersh, L.B. 1971: 5-Hydroxy-N-methylpyroglutamate synthetase. Evidence for an -ketoglutaryl enzyme intermediate from partitioning studies. Journal of Biological Chemistry 246(22): 6803-6806
Tennyson, V.M.; Heikkila, R.; Mytilineou, C.; Côté, L.; Cohen, G. 1974: 5-Hydroxydopamine 'tagged' neuronal boutons in rabbit neostriatum: interrelationship between vesicles and axonal membrane. Brain Research 82(2): 341-348
Sjöström, R.; Roos, B.E. 1972: 5-Hydroxyindolacetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis. European Journal of Clinical Pharmacology 4(3): 170-176
Andersson, H.; von Essen, C.; Roos, B.E. 1973: 5-Hydroxyindole acetic acid and homovanillic acid in cerebrospinal fluid after intrathecal and intravenous administration of probenecid to normal and hydrocephalic dogs. Acta Pharmacologica et Toxicologica 32(1): 139-147
Sjöström, R. 1973: 5-Hydroxyindole acetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis and the effect of probenecid treatment. European Journal of Clinical Pharmacology 6(2): 75-80
Murray-Lyon, I.M.; Sandler, M.; Cheetham, H.D.; Watts, J.A.; Williams, R. 1972: 5-Hydroxyindole-secreting rectal carcinoid tumour. Gut 13(5): 385-386
Van Dyke, D.H.; Cserr, H.; Barlow, C.F. 1970: 5-Hydroxyindoleacetic acid (5-HIAA) transport by isolated choroid plexus. Neurology 20(4): 393-394
Bowers, M.B. 1973: 5-Hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) following probenecid in acute psychotic patients treated with phenothiazines. Psychopharmacologia 28(4): 309-318
Johannsson, B.; Roos, B.E. 1974: 5-Hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid of patients with neurological diseases. European Neurology 11(1): 37-45
Dychko, E.N.; Mirtovskaia, V.N.; Sirota, G.I.; Shevchenko, L.V. 1982: 5-Hydroxyindoleacetic acid excretion in patients with the glossalgia syndrome. Stomatologiia 61(1): 34-35
Molnár, G.; Fodor, A.; Karczag, I.; Szilágyi, A.; Ujvárosi, I. 1973: 5-Hydroxyindoleacetic acid in cerebrospinal fluid. Acta Medica Academiae Scientiarum Hungaricae 30(3): 211-217
Johansson, B.; Roos, B.E. 1971: 5-Hydroxyindoleacetic acid in cerebrospinal fluid of patients with Parkinson's syndrome treated with L dopa. European Journal of Clinical Pharmacology 3(4): 232-235
Radulovacki, M. 1973: 5-Hydroxyindoleacetic acid in cerebrospinal fluid: measurements in wakefulness, slow-wave and paradoxical sleep. Brain Research 50(2): 484-488
Cohen, A.H.; Bowers, M.B. 1972: 5-Hydroxyindoleacetic acid in rat forebrain and cerebrospinal fluid following dorsal and median midbrain raphe lesions. Brain Research 39(2): 519-522
Zivković, B.; Bulat, M. 1971: 5-Hydroxyindoleacetic acid in the spinal cord and spinal fluid. Pharmacology 6(4): 209-215
Lidberg, L.; Asberg, M.; Sundqvist-Stensman, U.B. 1984: 5-Hydroxyindoleacetic acid levels in attempted suicides who have killed their children. Lancet 2(8408): 928
Young, S.N.; Lal, S.; Martin, J.B.; Ford, R.M.; Sourkes, T.L. 1973: 5-Hydroxyindoleacetic acid, homovanillic acid and tryptophan levels in CSF above and below a complete block of CSF flow. Psychiatria Neurologia Neurochirurgia 76(6): 439-444
Dubowitz, V.; Rogers, K. 1969: 5-Hydroxyindoles in mongolism and hydrocephalus. Archives of Disease in Childhood 44(238): 783
Anisymova, N.I.; Gabrilovich, I.M.; Soshina, N.V.; Cherenkevich, S.N. 1969: 5-Hydroxymethylcytosine-containing Klebsiella bacteriophage. Biochimica et Biophysica Acta 190(1): 225-227
Chang, A.Y.; Noble, R.E. 1980: 5-Hydroxymethylfurfural-forming proteins in the renal glomeruli of control and streptozotocin-diabetic rats. Life Sciences 26(16): 1329-1333
Krauze, S.; Miśkiewicz, W.; Pietrusińska, H. 1970: 5-Hydroxymethylfurfurol in stored and in heated honey. Roczniki Panstwowego Zakladu Higieny 21(5): 543-552
Uematsu, T.; Suhadolnik, R.J. 1973: 5-Hydroxymethyltubercidin. Synthesis, biological activity, and role in pyrrolopyrimidine biosynthesis. Journal of Medicinal Chemistry 16(12): 1405-1407
Rae, P.M. 1973: 5-Hydroxymethyluracil in the DNA of a dinoflagellate. Proceedings of the National Academy of Sciences of the United States of America 70(4): 1141-1145
Sward, J. 1973: 5-Hydroxytryptamine (5-HP) level in human placenta in the last week of pregnancy. Wiadomosci Lekarskie 26(17): 1607-1610
Enns, L.; McCoy, E.E.; Sneddon, J.N. 1983: 5-Hydroxytryptamine (5-HT) transport in Down's syndrome blood platelets: effect of K+ loading. Biochemical Pharmacology 32(11): 1793-1795
Luscombe, G.; Jenner, P.; Marsden, C.D. 1984: 5-Hydroxytryptamine (5-HT)-dependent myoclonus in guinea pigs is induced through brainstem 5-HT-1 receptors. Neuroscience Letters 44(3): 241-246
Li, E.T.; Anderson, G.H. 1984: 5-Hydroxytryptamine : a modulator of food composition but not quantity?. Life Sciences 34(25): 2453-2460
Weil-Fugazza, J.; Godefroy, F. 1971: 5-Hydroxytryptamine and 5-hydroxy-indoleacetic acid level of plasma after 5-hydroxytryptamine perfusion in dogs. Journal de Physiologie 63(6): 300a
Ahtee, L.; Eriksson, K. 1972: 5-Hydroxytryptamine and 5-hydroxyindolylacetic acid content in brain of rat strains selected for their alcohol intake. Physiology and Behavior 8(1): 123-126
Beart, P.M.; McDonald, D. 1982: 5-Hydroxytryptamine and 5-hydroxytryptaminergic-dopaminergic interactions in the ventral tegmental area of rat brain. Journal of Pharmacy and Pharmacology 34(9): 591-593
Roberts, M.H. 1984: 5-Hydroxytryptamine and antinociception. Neuropharmacology 23(12b): 1529-1536
Nilsson, O.; Cassuto, J.; Larsson, P.A.; Jodal, M.; Lidberg, P.; Ahlman, H.; Dahlström, A.; Lundgren, O. 1983: 5-Hydroxytryptamine and cholera secretion: a histochemical and physiological study in cats. Gut 24(6): 542-548
Dyer, D.C.; Weber, L.J. 1971: 5-Hydroxytryptamine and monoamine oxidase in adult and foetal sheep blood vessels. Journal of Pharmacy and Pharmacology 23(7): 549-550
Storm-Mathisen, J.; Guldberg, H.C. 1974: 5-Hydroxytryptamine and noradrenaline in the hippocampal region: effect of transection of afferent pathways on endogenous levels, high affinity uptake and some transmitter-related enzymes. Journal of Neurochemistry 22(5): 793-803
Sicuteri, F.; Anselmi, B.; Franchi, G.; Fanciullacci, M.; Del Bianco, P.L. 1972: 5-Hydroxytryptamine and physiopathology of pain; on a polyalgic syndrome in the course of therapy with para-chlorophenylalanine. La Clinica Terapeutica 61(6): 491-501
Meyerson, B.J.; Carrer, H.; Eliasson, M. 1974: 5-Hydroxytryptamine and sexual behavior in the female rat. Advances in Biochemical Psychopharmacology 11: 229-242
King, C.D. 1974: 5-Hydroxytryptamine and sleep in the cat: a brief overview. Advances in Biochemical Psychopharmacology 11: 211-216
Kirby, M. 1972: 5-Hydroxytryptamine antagonists related to cinanserin in human isolated smooth muscle. Journal of Pharmacy and Pharmacology 24(1): 67-68
Cardot, J. 1974: 5-Hydroxytryptamine biosynthesis in nervous tissue and myocardium of Helix pomatia. new results. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 168(10-11): 1269-1274
Talbot, P.; Schroeder, P.C. 1982: 5-Hydroxytryptamine causes contraction of smooth muscle cells in preovulatory hamster follicles. Journal of Experimental Zoology 224(3): 427-436
Cazzullo, C.L.; Brazzelli, C.A.; Giordano, P.L. 1969: 5-Hydroxytryptamine content in rabbits brain in experimental allergic encephalomyelitis. International Archives of Allergy and Applied Immunology 36: Suppl: 234-46
Hodge, G.K.; Butcher, L.L. 1974: 5-Hydroxytryptamine correlates of isolation-induced aggression in mice. European Journal of Pharmacology 28(2): 326-337
Mélon, J.; Lecomte, J. 1967: 5-Hydroxytryptamine does not participate, in man, in nasal anaphylactic reactions. Acta Allergologica 22(5): 373-377
Valzelli, L. 1974: 5-Hydroxytryptamine in aggressiveness. Advances in Biochemical Psychopharmacology 11: 255-263
Pare, C.M.; Trenchard, A.; Turner, P. 1974: 5-Hydroxytryptamine in depression. Advances in Biochemical Psychopharmacology 11: 275-279
Rolf, L.H.; Wiele, G.; Brune, G.G. 1981: 5-Hydroxytryptamine in platelets of patients with muscle contraction headache. Headache 21(1): 10-11
Baumgartner, H.R.; Born, G.V. 1968: 5-Hydroxytryptamine in rabbit platelets and their aggregation. Journal of Physiology 194(2): 92
Opatrný, K.; Sídlová, A.; Sova, J.; Hůla, J.; Cajzl, L.; Vlková, M.; Láhn, V.; Cepelák, V.; Schwartz, A.; Cerhová, M.; Levý, J. 1968: 5-Hydroxytryptamine in the blood of patients with carcinoid syndrome. Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 23(18): 556-561
Ahtee, L.; Pentikäinen, L.; Pentikäinen, P.J.; Paasonen, M.K. 1974: 5-Hydroxytryptamine in the blood platelets of cirrhotic and hypertensive patients. Experientia 30(11): 1328-1329
Braak, H.; Baumgarten, H.G.; Falck, B. 1968: 5-Hydroxytryptamine in the brain of the lizard (Lacerta viridis and Lacerta muralis). Zeitschrift für Zellforschung und mikroskopische Anatomie 90(2): 161-185
Coppen, A.; Wood, K. 1982: 5-Hydroxytryptamine in the pathogenesis of affective disorders. Advances in Biochemical Psychopharmacology 34: 249-258
Ehinger, B.; Hansson, C.; Tornqvist, K. 1981: 5-Hydroxytryptamine in the retina of some mammals. Experimental Eye Research 33(6): 663-672
Ho, R.H.; LaValley, A.L. 1984: 5-Hydroxytryptamine in the spinal cord of the domestic fowl. Brain Research Bulletin 13(3): 427-431
Chand, N. 1981: 5-Hydroxytryptamine induces relaxation of goat pulmonary veins: evidence for the noninvolvement of M and D-tryptamine receptors. British Journal of Pharmacology 72(2): 233-237
Hilton, B.P.; Cumings, J.N. 1972: 5-Hydroxytryptamine levels and platelet aggregation responses in subjects with acute migraine headache. Journal of Neurology Neurosurgery and Psychiatry 35(4): 505-509
Ashcroft, G.W.; Crawford, T.B.; Cundall, R.L.; Davidson, D.L.; Dobson, J.; Dow, R.C.; Eccleston, D.; Loose, R.W.; Pullar, I.A. 1973: 5-Hydroxytryptamine metabolism in affective illness: the effect of tryptophan administration. Psychological Medicine 3(3): 326-332
Eccleston, D.; Reading, W.H.; Ritchie, I.M. 1969: 5-Hydroxytryptamine metabolism in brain and liver slices and the effect of ethanol. Journal of Neurochemistry 16(2): 274-276
Tyce, G.M.; Flock, E.V.; Owen, C.A. 1968: 5-Hydroxytryptamine metabolism in brains of ethanol-intoxicated rats. Mayo Clinic Proceedings 43(9): 668-673
Igari, T.; Toba, Y.; Obara, K.; Ono, S. 1974: 5-Hydroxytryptamine metabolism in joint diseases. Tohoku Journal of Experimental Medicine 112(4): 355-359
Feldstein, A.; Williamson, O. 1968: 5-Hydroxytryptamine metabolism in rat brain and liver homogenates. British Journal of Pharmacology 34(1): 38-42
Trulson, M.; Randall, W. 1973: 5-Hydroxytryptamine metabolism, superior colliculus, and grooming behavior in cats with pontile lesions. Journal of Comparative and Physiological Psychology 85(1): 1-10
Kaltiala, E.H.; Heikkinen, E.S.; Kärki, N.T. 1968: 5-Hydroxytryptamine of intestine and blood after high intestinal obstruction in rats. Annales Medicinae Experimentalis et Biologiae Fenniae 46(3): 508-510
Fillion, G.; Beaudoin, D.; Fillion, M.P.; Rousselle, J.C.; Robaut, C.; Netter, Y. 1983: 5-Hydroxytryptamine receptors in neurones and glia. Journal of Neural Transmission. Supplementum 18: 307-317
Lamar, J.C.; Edvinsson, L. 1980: 5-Hydroxytryptamine receptors. Contractile activity and mode of inhibition by methysergide in mammalian intracranial and extracranial vessels. Archives Internationales de Pharmacodynamie et de Therapie 243(2): 245-254
Davies, J.E.; Roberts, M.H. 1981: 5-Hydroxytryptamine reduces substance P responses on dorsal horn interneurones: a possible interaction of neurotransmitters. Brain Research 217(2): 399-404